RESULT_COUNT: 302,PAGE_SIZE: 10000,CURRENT_PAGE: 1,TOTAL_PAGES: 1,API_CALL_CREDITS: 1
TICKER,FIGI_TICKER,FIGI,TITLE,PUBLICATION_DATE,URL,SUMMARY
ONCE,ONCE:UW,BBG007TJWN87,[$$] Gormley's Take: Gene Therapy Finally Hitting Pay Dirt,2017-10-20 11:30:07 +0000,http://finance.yahoo.com/r/86dbafc3-b43b-3863-8a75-8979cf85b031/gormleys-take-gene-therapy-finally-hitting-pay-dirt-1508499001?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,"After decades of dreams unfulfilled, gene therapy is finally having its day in the sun."
ONCE,ONCE:UW,BBG007TJWN87,PBS's Documentary 'The Gene Doctors' Arrives Amid A Gene Therapy Boom,2017-10-19 13:48:00 +0000,http://finance.yahoo.com/r/c3a9a406-1d46-355b-97ca-c0abc516d9eb/pbss-documentary-the-gene-doctors-arrives-amid-a-gene-therapy-boom?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix&yptr=yahoo&.tsrc=rss,A new PBS film educates viewers about gene therapy at a time when the once controversial field of research is starting to bear fruit.
ONCE,ONCE:UW,BBG007TJWN87,"Biotech Stock Roundup: Exelixis Soars on Priority Review, FDA Panel Supports Spark Drug",2017-10-18 11:32:11 +0000,https://finance.yahoo.com/news/biotech-stock-roundup-exelixis-soars-113211834.html?.tsrc=rss,Key highlights include regulatory updates from Exelixis (EXEL) and Spark Therapeutics and pipeline updates from Regeneron and Ionis among others.
ONCE,ONCE:UW,BBG007TJWN87,See what the IHS Markit Score report has to say about Spark Therapeutics Inc.,2017-10-17 12:04:37 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120437289.html?.tsrc=rss,Spark Therapeutics Inc NASDAQ/NGS:ONCE
ONCE,ONCE:UW,BBG007TJWN87,Spark Therapeutics’ promising gene therapy for vision loss could cost $1 million,2017-10-16 12:35:11 +0000,http://finance.yahoo.com/r/41d8c4c5-cdd7-34e7-a019-fc95ad42cf68/Story.aspx?guid=606E4072-B030-11E7-9D86-9DB78C436C0A&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"The development could be a major, if costly, milestone for both the disease and the field of gene therapy."
ONCE,ONCE:UW,BBG007TJWN87,See what the IHS Markit Score report has to say about Spark Therapeutics Inc.,2017-10-16 12:04:37 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120437320.html?.tsrc=rss,"The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.  Index (PMI) data, output in the Healthcare sector is rising."
ONCE,ONCE:UW,BBG007TJWN87,Edited Transcript of ONCE earnings conference call or presentation 2-Aug-17 12:30pm GMT,2017-10-14 22:10:48 +0000,https://finance.yahoo.com/news/edited-transcript-once-earnings-conference-154554948.html?.tsrc=rss,Q2 2017 Spark Therapeutics Inc Earnings Call
ONCE,ONCE:UW,BBG007TJWN87,How Spark's Gene Therapy Win Could Also Be A Boon For These Biotechs,2017-10-13 22:16:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Es_cHrfg1D8/how-sparks-gene-therapy-win-could-also-be-a-boon-for-these-biotechs-cm859500,Spark Therapeutics ONCE positive vote by a Food and Drug Administration committee could be a boon for other drugmakers working on gene therapies including Audentes Therapeutics BOLD BioMarin Pharmaceutical BMRN and Ultragenyx
ONCE,ONCE:UW,BBG007TJWN87,All The Sell-Side Responses To Spark Therapeutics' Strong AdCom Meeting On Luxturna,2017-10-13 16:55:41 +0000,https://finance.yahoo.com/news/sell-side-responses-spark-therapeutics-165541237.html?.tsrc=rss,"On Thursday afternoon, and FDA advisory panel recommended approval of Spark Therapeutics Inc (NASDAQ: ONCE )’s Luxturna treatment for inherited blindness. A number of Wall Street analysts weighed in on ..."
ONCE,ONCE:UW,BBG007TJWN87,Gene Therapies: A Foot in the Door,2017-10-13 16:31:00 +0000,http://finance.yahoo.com/r/683315b9-6c82-3cf3-8c60-ddcfb7620f88/gene-therapies-a-foot-in-the-door-1507912303?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"The yes vote by the FDA advisory panel for Spark Therapeutics’ (ONCE) drug Luxturna has opened the door for gene therapies at the FDA.  Leerink’s Joseph Schwartz weighed in on that very topic today.  Proclaiming it “a new era for gene therapy,” he says the results of yesterday’s vote is a “momentous advance” for the drug category that suggests that the public’s and regulators’ long-standing caution is “at an inflection point.” If the FDA follows-through on today's unanimous vote and approves Luxturna by Jan 12, 2018, we believe the tailwind could benefit companies like Audentes (BOLD [OP]), BioMarin (BMRN [OP]), REGENXBIO (RGNX [NR]), uniQure (QURE [OP]) and Ultragenyx (RARE [OP]) post-DMTX acquisition."
ONCE,ONCE:UW,BBG007TJWN87,How Spark&apos;s Gene Therapy Win Could Also Be A Boon For These Biotechs,2017-10-13 16:09:05 +0000,http://finance.yahoo.com/r/597ea164-2154-37fe-b395-0610fa76a9f5/how-sparks-gene-therapy-win-could-also-be-a-boon-for-these-biotechs?src=A00220&yptr=yahoo&.tsrc=rss,"Spark&apos;s positive vote by an FDA committee could be a boon for other drugmakers working on gene therapies including Audentes, BioMarin and Ultragenyx."
ONCE,ONCE:UW,BBG007TJWN87,Spark: A Big Win for Gene Therapy. So Why Is It Falling?,2017-10-13 15:55:00 +0000,http://finance.yahoo.com/r/5bd4124a-682b-3423-8ddf-985d97fc08ef/spark-a-big-win-for-gene-therapy-so-why-is-it-falling-1507910155?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"It looks like Spark Therapeutics’ (ONCE) experimental gene therapy Luxturna is on track to become the first therapy meant to replace or repair a defective gene approved in the U.S. Late Thursday, a panel of independent FDA advisors voted unanimously to recommend that the agency approve the drug, called Luxturna, which is designed to treat patients with vision loss due to an inherited retinal disease.  The FDA is due to issue a decision by Jan. 12.  BMO Capital Markets and Stifel both see the stock reaching $101 a share by this time next year."
ONCE,ONCE:UW,BBG007TJWN87,Is Spark Therapeutics’ Luxturna a Game Changer?,2017-10-13 14:45:56 +0000,https://finance.yahoo.com/news/spark-therapeutics-luxturna-game-changer-144556851.html?.tsrc=rss,Shares of Spark Therapeutics saw a handy gain to close out the week after the FDA recommended approval of Luxturna.
ONCE,ONCE:UW,BBG007TJWN87,3 Highlights From A Spark Therapeutics Fireside Chat,2017-10-13 13:36:24 +0000,https://finance.yahoo.com/news/3-highlights-spark-therapeutics-fireside-133624472.html?.tsrc=rss,Analysts at Jefferies hosted a fireside chat-themed conversation with Spark Therapeutics Inc (NASDAQ: ONCE ) to discuss the company's successes from Thursday's FDA panel . Analyst Michael Yee maintains ...
ONCE,ONCE:UW,BBG007TJWN87,Spark Therapeutics: Inside The Dramatic FDA AdCom Meeting,2017-10-13 12:25:05 +0000,https://finance.yahoo.com/news/spark-therapeutics-inside-dramatic-fda-122505566.html?.tsrc=rss,Analysts at Cantor Fitzgerald continue to hold a bullish stance on Spark Therapeutics Inc (NASDAQ: ONCE ) after the U.S. Food and Drug Administration gave the company a critical recommendation for its ...
ONCE,ONCE:UW,BBG007TJWN87,Spark Therapeutics shares jump 7.5% after FDA committee backs blindness treatment,2017-10-13 11:41:21 +0000,http://finance.yahoo.com/r/40ceeb54-0af8-3475-8836-e55dc99c3e6e/Story.aspx?guid=F8D9B09C-260B-4244-B2C0-08EEB5A7A7D5&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"Shares of Spark Therapeutics Inc. surged 7.5% premarket Friday, after a U.S. Food and Drugs Administration advisory committee recommended approval of the company's gene therapy treatment for a rare eye ..."
ONCE,ONCE:UW,BBG007TJWN87,"3 Stocks to Watch on Friday: Baxter International Inc (BAX), Exfo Inc (EXFO) and Spark Therapeutics Inc (ONCE)",2017-10-13 11:05:55 +0000,https://finance.yahoo.com/news/3-stocks-watch-friday-baxter-110555786.html?.tsrc=rss,"Baxter International Inc (NYSE:BAX) shares took a hit after the bell, while Exfo Inc (NASDAQ:EXFO) and Spark Therapeutics Inc (NASDAQ:ONCE) stocks both rose.  Baxter International shares fell after the company updated its guidance."
ONCE,ONCE:UW,BBG007TJWN87,"ONCE Sparkles, BDSI Makes Peace, Coming Event Casts Its Shadow Before ATRS",2017-10-13 02:01:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ez3wUSPO7sc/once-sparkles-bdsi-makes-peace-coming-event-casts-its-shadow-before-atrs-20171013-00034,"ONCE Sparkles, BDSI Makes Peace, Coming Event Casts Its Shadow Before ATRS"
ONCE,ONCE:UW,BBG007TJWN87,FDA Advisory Committee Greenlights First Gene Therapy for Inherited Disorder,2017-10-12 23:26:00 +0000,http://finance.yahoo.com/r/cc753b93-6a8b-369d-b67f-0b73b52a9b69/fda-advisory-committee-greenlights-first-gene-therapy-for-inherited-disorder.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Spark Therapeutics gains gene therapy advisory OK for treatment restoring some sight for patients facing eventual blindness.
ONCE,ONCE:UW,BBG007TJWN87,Spark Therapeutics Gains Panel Nod For Gene Therapy To Treat Blindness,2017-10-12 21:31:21 +0000,http://finance.yahoo.com/r/daca0fdb-299a-3060-a130-5a63e393238e/spark-therapeutics-gains-panel-nod-for-gene-therapy-to-treat-blindness?src=A00220&yptr=yahoo&.tsrc=rss,"A gene therapy from Spark Therapeutics to treat a rare eye disease should gain full FDA approval, reports say."
ONCE,ONCE:UW,BBG007TJWN87,Spark Therapeutics jumps after favorable FDA panel vote,2017-10-12 21:14:00 +0000,https://finance.yahoo.com/video/spark-therapeutics-jumps-favorable-fda-211400330.html?.tsrc=rss,CNBC's Meg Tirrell reports on Spark Therapeutics shares jumping after the FDA panel votes in favor of the company's gene therapy.
ONCE,ONCE:UW,BBG007TJWN87,FDA Advisory Committee Unanimously Recommends Approval of Investigational LUXTURNA™ (voretigene neparvovec) for Patients with Biallelic RPE65-mediated Inherited Retinal Disease,2017-10-12 20:51:35 +0000,https://finance.yahoo.com/news/fda-advisory-committee-unanimously-recommends-205135353.html?.tsrc=rss,Investigational LUXTURNA has the potential to be both the first pharmacologic treatment for an inherited retinal disease and the first gene therapy for a genetic disease in the United States. First adeno-associated ...
ONCE,ONCE:UW,BBG007TJWN87,U.S. FDA panel backs gene therapy for rare form of blindness,2017-10-12 20:23:38 +0000,https://finance.yahoo.com/news/fda-panel-votes-favor-sparks-194212664.html?.tsrc=rss,"Spark Therapeutics Inc's  experimental gene therapy for a rare form of blindness improves  vision and should be approved, advisers to the Food and Drug  Administration concluded on Thursday, paving the way for the  first U.S. gene therapy for an inherited disease.  The panel voted unanimously in favor of the treatment,  Luxturna, which is designed to treat inherited retinal diseases  caused by defects in a gene known as RPE65, which tells cells to  produce an enzyme critical to normal vision."
ONCE,ONCE:UW,BBG007TJWN87,[$$] US paves way for use of pioneering 'gene therapies',2017-10-12 20:20:41 +0000,"http://finance.yahoo.com/r/e5cf81c1-0b38-3b48-a347-878972bd47ee/d1f15874-af6d-11e7-aab9-abaa44b1e130,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev&yptr=yahoo&.tsrc=rss","A pioneering treatment that can reverse a form of childhood vision loss by inserting DNA directly into the eye is on track for regulatory approval in the US, after a panel of scientists endorsed unanimously ..."
ONCE,ONCE:UW,BBG007TJWN87,Landmark Therapy to Treat Blindness Gets One Step Closer to FDA Approval,2017-10-12 19:32:52 +0000,http://finance.yahoo.com/r/a0a4f516-8a6b-31ac-a4fd-ece08f40f995/spark-s-gene-therapy-to-treat-blindness-gets-closer-to-approval?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss,"A treatment that can stop patients from going blind is poised to be the first gene therapy for an inherited condition approved in the U.S., in what would be a major scientific milestone -- and also open the door for record-breaking drug prices and novel ways to pay for them.  Spark Therapeutics Inc.’s Luxturna therapy crossed a key hurdle Thursday when it won backing from a group of advisers to the U.S. Food and Drug Administration.  After discussing the trial design, treatment procedure and safety profile, the panel of 16 experts voted unanimously that the drug’s benefits outweighed its risks."
ONCE,ONCE:UW,BBG007TJWN87,Spark's gene therapy treatment receives 16-0 vote in favo...,2017-10-12 19:23:00 +0000,https://finance.yahoo.com/video/sparks-gene-therapy-treatment-receives-192300466.html?.tsrc=rss,"CNBC's Meg Tirrell reports that Spark Therapeutics has received a 16-0 vote from an FDA panel in favor of a new genetic treatment to treat a rare, inherited form of blindness"
ONCE,ONCE:UW,BBG007TJWN87,"The Time Has Come: 4 Gene Therapy Stocks to Buy, 1 to Avoid",2017-10-12 18:34:00 +0000,http://finance.yahoo.com/r/9cee1e19-080d-34fb-aa42-677bda25a0bf/the-time-has-come-4-gene-therapy-stocks-to-buy-1-to-avoid-1507833292?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"A panel of independent FDA advisors is meeting today to consider the merits of Luxturna, a one-time gene therapy developed by Spark Therapeutics (ONCE) meant to treat a rare form of childhood blindness.  If the panel votes to recommend the drug's approval, and the FDA follows that recommendation (as the agency usually does), Spark’s drug becomes the first therapy meant to replace or repair a defective gene approved in the U.S. There is a pack of other drug makers developing gene therapies, seveal of which were highlighted by Barron’s in a recent cover story.  In short, within the next few years, we expect multiple U.S. approvals of gene therapy products, with Spark’s LUXTURNA leading the pack in January 2018 (PDUFA)."
ONCE,ONCE:UW,BBG007TJWN87,"Sofinnova Management VIII, L.L.C. Buys NuCana PLC, Synlogic Inc, Sells Versartis Inc, Spark ...",2017-10-12 16:10:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JOAFmtiniH8/sofinnova-management-viii-llc-buys-nucana-plc-synlogic-inc-sells-versartis-inc-spark-cm858898,Sofinnova Management VIII L L C New Purchases NCNA SYBX Reduced Positions ONCE Sold Out VSAR INNL New Purchases NCNA SYBX New Purchases NCNA SYBX Reduced Positions ONCE Reduced Positions ONCE
ONCE,ONCE:UW,BBG007TJWN87,Spark Therapeutics shares halted as FDA committee reviews gene therapy treatment for eye disease,2017-10-12 11:41:02 +0000,http://finance.yahoo.com/r/5cd2a670-534e-334b-b2ef-b4b30fd28dfe/Story.aspx?guid=6287B08C-8ACD-4B39-A947-71C17BF5A7B4&siteid=yhoof2&yptr=yahoo&.tsrc=rss,Spark Therapeutics Inc. shares were halted Thursday as a U.S. Food and Drugs Administration advisory committee meets to review the company's gene therapy treatment for patients with vision loss caused ...
ONCE,ONCE:UW,BBG007TJWN87,Sparks Therapeutics' gene therapy treatment for blindness...,2017-10-12 11:31:00 +0000,https://finance.yahoo.com/video/sparks-therapeutics-gene-therapy-treatment-113100249.html?.tsrc=rss,CNBC's Meg Tirrell reports Sparks Therapeutics could be the first biotech company in the U.S. to get approval from the FDA to treat a rare form of blindness at its genetic root.
ONCE,ONCE:UW,BBG007TJWN87,Spark Therapeutics (ONCE) Trading of Stock Halted as FDA Advisory Committee Reviews Investigational Gene Therapy,2017-10-12 11:30:00 +0000,https://finance.yahoo.com/news/spark-therapeutics-once-trading-stock-113000723.html?.tsrc=rss,"PHILADELPHIA, Oct. 12, 2017-- Spark Therapeutics, a fully integrated gene therapy company dedicated to challenging the inevitability of genetic disease, announced today that NASDAQ has halted trading of ..."
ONCE,ONCE:UW,BBG007TJWN87,Here Come More Gene Therapies -- And More Pricing Debates,2017-10-11 12:35:00 +0000,http://finance.yahoo.com/r/bf13ad14-efdb-3683-80fd-3c333a2089f9/here-come-more-gene-therapies-and-more-pricing-debates?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix&yptr=yahoo&.tsrc=rss,"Gene therapies like Spark Therapeutics' upcoming Luxturna and Novartis' FDA-approved Kymriah are raising concerns about the rising cost of health care, leading some experts to suggest new ways to price treatments based on the benefits they offer."
ONCE,ONCE:UW,BBG007TJWN87,"ETFs with exposure to Spark Therapeutics, Inc. : October 10, 2017",2017-10-10 15:42:20 +0000,http://finance.yahoo.com/r/a919a976-3b34-3504-8371-864eafe3d87b/etfs-with-exposure-to-spark-therapeutics-inc-october-10-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Spark Therapeutics, Inc. Here are 5 ETFs with the largest exposure to ONCE-US. Comparing the performance and risk of Spark Therapeutics, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more
<b>(Read more...)</b>"
ONCE,ONCE:UW,BBG007TJWN87,"Spark gene therapy improves vision, at least in short term-FDA",2017-10-10 14:01:23 +0000,https://finance.yahoo.com/news/spark-gene-therapy-improves-vision-140123675.html?.tsrc=rss,"The therapy, Luxturna, or voretigene neparvovec, would be the first-ever gene therapy for any inherited disease to be approved in the United States.  The FDA's review, posted on Tuesday on the agency's website, comes two days ahead of a meeting of outside advisers who will discuss the treatment and recommend whether it should be approved.  Michael Yee, an analyst at Jefferies, said the FDA documents ""look fairly benign and as expected,"" and that he expects the advisory panel is likely to vote in favour of approval."
ONCE,ONCE:UW,BBG007TJWN87,Spark's blindness gene therapy reviewed by U.S. FDA,2017-10-10 12:28:54 +0000,https://finance.yahoo.com/news/sparks-blindness-gene-therapy-reviewed-122854565.html?.tsrc=rss,"Spark Therapeutics Inc's  experimental gene therapy for a rare inherited form of blindness  is effective, though it is unclear whether the benefit lasts  over time, according to a preliminary review by the U.S. Food  and Drug Administration.  The therapy, Luxturna, or voretigene neparvovec, would be  the first ever gene therapy for an inherited disease to be  approved in the United States.  The FDA's review, posted on Tuesday on the agency's website,  comes two days ahead of a meeting of outside advisors who will  discuss the treatment and recommend whether it should be  approved."
ONCE,ONCE:UW,BBG007TJWN87,Spark Therapeutics Reaches Analyst Target Price,2017-10-03 16:58:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/i1iUkbUbwFY/spark-therapeutics-reaches-analyst-target-price-cm854639,In recent trading shares of Spark Therapeutics Inc Symbol ONCE have crossed above the average analyst 12 month target price of 89 33 changing hands for 89 37 share When a stock reaches the target an analyst has set the analyst logically has two ways to react downgrade on valuation
ONCE,ONCE:UW,BBG007TJWN87,Spark Therapeutics to Participate in Multiple Conferences in October,2017-10-03 11:30:00 +0000,https://finance.yahoo.com/news/spark-therapeutics-participate-multiple-conferences-113000500.html?.tsrc=rss,"PHILADELPHIA, Oct. 03, 2017-- Spark Therapeutics, a fully integrated gene therapy company dedicated to challenging the inevitability of genetic disease, today announced that company management will present ..."
ONCE,ONCE:UW,BBG007TJWN87,"ETFs with exposure to Spark Therapeutics, Inc. : September 29, 2017",2017-09-29 14:36:09 +0000,http://finance.yahoo.com/r/bc4ff86a-c49f-3a00-b865-7ec833a0aab0/etfs-with-exposure-to-spark-therapeutics-inc-september-29-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Spark Therapeutics, Inc. Here are 5 ETFs with the largest exposure to ONCE-US. Comparing the performance and risk of Spark Therapeutics, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more
<b>(Read more...)</b>"
ONCE,ONCE:UW,BBG007TJWN87,8 Stocks for the Next Gene Revolution,2017-09-29 10:00:00 +0000,http://finance.yahoo.com/r/7c8e8c7b-e625-39fc-bad8-0aac068708b9/8-stocks-next-gene-revolution?partner=YahooSA&yptr=yahoo&.tsrc=rss,"The FDA may approve replacement gene therapy for the first time, giving a big boost to biotech firms."
ONCE,ONCE:UW,BBG007TJWN87,Biotech Stocks Facing FDA Decision In October,2017-09-29 07:52:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nmihicMyCXk/biotech-stocks-facing-fda-decision-in-october-20170929-00332,Biotech Stocks Facing FDA Decision In October
ONCE,ONCE:UW,BBG007TJWN87,Gene Therapy: A Big Week for Many Names,2017-09-25 14:47:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/cdGvwJIxtoE/gene-therapy-a-big-week-for-many-names-cm850359,It s been a big week for the gene therapy universe It s been a big week for the gene therapy universe Of course there s the latest Barron s cover story which details the emerging medical revolution and highlights three stocks AveXis AVXS Regenxbio RGNX and Spark
ONCE,ONCE:UW,BBG007TJWN87,"Spark Therapeutics Further Expands Gene Therapy Expertise with Appointment of Federico Mingozzi, Ph.D., as Chief Scientific Officer",2017-09-25 11:30:00 +0000,https://finance.yahoo.com/news/spark-therapeutics-further-expands-gene-113000625.html?.tsrc=rss,"PHILADELPHIA, Sept. 25, 2017-- Spark Therapeutics, a fully integrated gene therapy company dedicated to challenging the inevitability of genetic disease, today announced the appointment of Federico Mingozzi, ..."
ONCE,ONCE:UW,BBG007TJWN87,[$$] Gene Therapy Is Nearing a Major Breakthrough,2017-09-25 04:01:00 +0000,http://finance.yahoo.com/r/0cc44cf1-ce16-3c9e-85bb-26fdfbce3cc5/gene-therapy-is-nearing-a-major-breakthrough-1506140340?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"After decades of research and development, gene therapy is rapidly emerging as one of the most exciting areas in biotechnology—and generating new hope for patients with certain rare and often deadly inherited diseases.  Replacement gene therapy that uses neutered viruses to deliver healthy genes to the body is particularly promising, given its potential to cure a range of disorders with the administration of a single treatment.  The first regulatory approval for this technology could come as soon as January, if the Food and Drug Administration gives the go-ahead to Spark Therapeutics (ONCE) for its one-time treatment that targets a rare, inherited retinal condition leading to blindness."
ONCE,ONCE:UW,BBG007TJWN87,Spark Therapeutics signs gene therapy deal with French nonprofit,2017-09-20 17:30:11 +0000,http://finance.yahoo.com/r/42c55cad-d8e8-32aa-b2a2-9a7e35784b3a/spark-therapeutics-signs-gene-therapy-deal-with.html?ana=yahoo&yptr=yahoo&.tsrc=rss,"Spark Therapeutics said Wednesday it has entered into a licensing agreement with Genethon for the development and commercialization of an adeno-associated viral gene therapy targeting the liver to address a rare genetic disease.  Genethon, based in France, is a nonprofit research-and-development organization working on the development of gene therapies — from research to clinical validation — for orphan genetic diseases.  Under the terms of the deal, Spark (ONCE) has the option to develop and commercialize any gene therapy that results from licensing agreement."
ONCE,ONCE:UW,BBG007TJWN87,Spark Therapeutics Enters into Licensing Agreement with Genethon,2017-09-20 11:30:00 +0000,https://finance.yahoo.com/news/spark-therapeutics-enters-licensing-agreement-113000765.html?.tsrc=rss,"PHILADELPHIA and EVRY, France, Sept. 20, 2017-- Spark Therapeutics, a fully integrated gene therapy company dedicated to challenging the inevitability of genetic disease, today announced it has entered ..."
ONCE,ONCE:UW,BBG007TJWN87,RBC Launches Biotech Sector Coverage Amid 'An Innovation Revolution',2017-09-14 20:52:00 +0000,http://finance.yahoo.com/r/0f7f86bb-fddc-3516-921a-b7d578b017c8/rbc-launches-biotech-sector-coverage-amid-an-innovation-revolution-1505422378?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"RBC Capital Markets just launched coverage of the biotech sector, covered by Brian Abrahams, Kennen MacKay, and Matthew Eckler, and they spoke with Barrons.com about the industry, which they say is seeing a number of exciting innovations as we enter a new era of personalized medicine.  Of course, biotech has been on a wild ride in recent years, but after being shunned by a number of investors previously, the sector is seeing new life in 2017, with the Nasdaq Biotechnology Index (NBI) up more than 25% this year, and SPDR S&P Biotech ETF (XBI) up more than 40%."
ONCE,ONCE:UW,BBG007TJWN87,"ETFs with exposure to Spark Therapeutics, Inc. : September 13, 2017",2017-09-13 23:23:19 +0000,http://finance.yahoo.com/r/f97ef73b-27e9-3fef-89cf-d7f7b84d7d5d/etfs-with-exposure-to-spark-therapeutics-inc-september-13-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Spark Therapeutics, Inc. Here are 5 ETFs with the largest exposure to ONCE-US. Comparing the performance and risk of Spark Therapeutics, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more
<b>(Read more...)</b>"
ONCE,ONCE:UW,BBG007TJWN87,See what the IHS Markit Score report has to say about Spark Therapeutics Inc.,2017-09-12 12:07:20 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120720466.html?.tsrc=rss,Spark Therapeutics Inc NASDAQ/NGS:ONCE
ONCE,ONCE:UW,BBG007TJWN87,"Spark Therapeutics, Inc. :ONCE-US: Earnings Analysis: Q2, 2017 By the Numbers : September 11, 2017",2017-09-11 18:13:23 +0000,http://finance.yahoo.com/r/ef8b8d5c-de5e-35ad-a587-165a06666d37/spark-therapeutics-inc-once-us-earnings-analysis-q2-2017-by-the-numbers-september-11-2017?yptr=yahoo&.tsrc=rss,"Categories:  Yahoo FinanceGet free summary analysis Spark Therapeutics, Inc. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of Spark Therapeutics, Inc. – Immunomedics, Inc., Harvard Bioscience, Inc., FibroGen, Inc. and Illumina, Inc. (IMMU-US, HBIO-US, FGEN-US and ILMN-US) that have also reported for this period. Highlights Summary ... Read more
<b>(Read more...)</b>"
ONCE,ONCE:UW,BBG007TJWN87,Breaking Down Barclays' New Bullish Calls On Biotech,2017-09-07 19:32:52 +0000,https://finance.yahoo.com/news/breaking-down-barclays-bullish-calls-193252995.html?.tsrc=rss,"Barclays initiated coverage of the U.S. small- and mid-cap biotechnology industry with a Positive view, as it expects the outperformance of the sector relative to the S&P 500 to continue in the next 12-18 ..."
ONCE,ONCE:UW,BBG007TJWN87,3 Stocks Your Children Will Brag About Someday,2017-09-07 14:54:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YXjtqYzcfKE/3-stocks-your-children-will-brag-about-someday-cm842210,We Fools believe that holding great companies over long periods is the best way to grow wealthy So which stocks do we think are great buy and hold candidates today We asked that question to a team of investors and they picked Activision Blizzard NASDAQ ATVI Home Depot
ONCE,ONCE:UW,BBG007TJWN87,3 Stocks Your Children Will Brag About Someday,2017-09-07 13:15:00 +0000,http://finance.yahoo.com/r/9e5caeb5-6bfc-3e04-b927-da88d9ab6104/3-stocks-your-children-will-brag-about-someday.aspx?yptr=yahoo&.tsrc=rss,"Activision Blizzard, Home Depot, and Spark Therapeutics all look poised to deliver for their shareholders for years to come."
ONCE,ONCE:UW,BBG007TJWN87,How investors should play gene-therapy stocks,2017-09-07 01:12:30 +0000,http://finance.yahoo.com/r/190366c7-f455-3e11-8efe-ce74d6f622a2/Story.aspx?guid=0AFE9B7C-9263-11E7-8771-BBAD9CFED079&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"Medical moonshots are successful only after many years of research, so investors need to take a long-term view, says Ethan Lovell."
ONCE,ONCE:UW,BBG007TJWN87,Here's Why Spark Therapeutics Inc. Surged 23.5% in August,2017-09-06 22:50:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fVnyQ3I0p00/heres-why-spark-therapeutics-inc-surged-235-in-august-cm841959,What happened Shares of Spark Therapeutics Inc NASDAQ ONCE a clinical stage biotech developing gene therapies rose 23 5 in August according to data from S amp P Global Market Intelligence The company pleased investors with clinical trial data for a hemophilia drug
ONCE,ONCE:UW,BBG007TJWN87,Here&apos;s Why Spark Therapeutics Inc. Surged 23.5% in August,2017-09-06 21:00:00 +0000,http://finance.yahoo.com/r/a8b12aef-417c-373b-b005-6136ac64c425/heres-why-spark-therapeutics-inc-surged-235-in-aug.aspx?yptr=yahoo&.tsrc=rss,Revealing positive clinical trial data for a bleeding-disorder candidate increased confidence for the company&apos;s proprietary gene therapy development platform.
ONCE,ONCE:UW,BBG007TJWN87,Spark Therapeutics Is Ready to Catch Fire,2017-09-06 19:59:00 +0000,http://finance.yahoo.com/r/25d03641-383a-3985-8ff8-a7c0f0e9e9c8/spark-therapeutics-ready-catch-fire?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Look for higher highs from this biotech play.
ONCE,ONCE:UW,BBG007TJWN87,See what the IHS Markit Score report has to say about Spark Therapeutics Inc.,2017-09-06 12:06:29 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120629031.html?.tsrc=rss,Spark Therapeutics Inc NASDAQ/NGS:ONCE
ONCE,ONCE:UW,BBG007TJWN87,"Spark Therapeutics Announces Publication of Study Confirming Novel Test’s Validity, Reliability and Ability to Detect Change in Functional Vision",2017-09-06 11:30:00 +0000,https://finance.yahoo.com/news/spark-therapeutics-announces-publication-study-113000183.html?.tsrc=rss,"PHILADELPHIA, Sept. 06, 2017-- Spark Therapeutics, a fully integrated gene therapy company dedicated to challenging the inevitability of genetic disease, today announced that Clinical and Experimental ..."
ONCE,ONCE:UW,BBG007TJWN87,Spark Therapeutics to Participate in Multiple Conferences in September,2017-08-30 11:30:00 +0000,https://finance.yahoo.com/news/spark-therapeutics-participate-multiple-conferences-113000908.html?.tsrc=rss,"PHILADELPHIA, Aug. 30, 2017-- Spark Therapeutics, a fully integrated gene therapy company dedicated to challenging the inevitability of genetic disease, today announced that company management will present ..."
ONCE,ONCE:UW,BBG007TJWN87,Harry Boxer: These three biotech stocks are breaking out,2017-08-24 16:51:09 +0000,http://finance.yahoo.com/r/fd52447e-7e8d-31dc-b7ea-0975a7ddfa5d/Story.aspx?guid=FCE75884-88E5-11E7-BE2B-E61E532BE66C&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"In focus: Array BioPharma, Immunomedics and Spark Therapeutics."
ONCE,ONCE:UW,BBG007TJWN87,See what the IHS Markit Score report has to say about Spark Therapeutics Inc.,2017-08-23 12:01:38 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120138749.html?.tsrc=rss,Spark Therapeutics Inc NASDAQ/NGS:ONCE
ONCE,ONCE:UW,BBG007TJWN87,7 Hot Stocks to Buy for High-Momentum Gains,2017-08-17 23:38:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2QklbMGfVAg/7-hot-stocks-to-buy-for-high-momentum-gains-cm833676,InvestorPlace Stock Market News Stock Advice amp Trading Tips About halfway through the ninth year of one of the greatest bull markets in American history momentum stocks might be the just the ticket for investors as we edge closer to the end of the party Source Shutterstock
ONCE,ONCE:UW,BBG007TJWN87,See what the IHS Markit Score report has to say about Spark Therapeutics Inc.,2017-08-12 12:03:06 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120306772.html?.tsrc=rss,Spark Therapeutics Inc NASDAQ/NGS:ONCE
ONCE,ONCE:UW,BBG007TJWN87,See what the IHS Markit Score report has to say about Spark Therapeutics Inc.,2017-08-11 12:03:26 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120326412.html?.tsrc=rss,Spark Therapeutics Inc NASDAQ/NGS:ONCE
ONCE,ONCE:UW,BBG007TJWN87,Spark Therapeutics Recognized as One of Philadelphia’s “Best Places to Work” by the Philadelphia Business Journal,2017-08-11 11:30:00 +0000,https://finance.yahoo.com/news/spark-therapeutics-recognized-one-philadelphia-113000444.html?.tsrc=rss,"PHILADELPHIA, Aug. 11, 2017-- Spark Therapeutics, a fully integrated gene therapy company dedicated to challenging the inevitability of genetic disease, announced today that it has been named one of the ..."
ONCE,ONCE:UW,BBG007TJWN87,CHOP spinout Spark completes $402M stock sale,2017-08-10 12:25:09 +0000,http://finance.yahoo.com/r/27e02792-7fea-32b9-9eae-8ec3d2f9ffe4/chop-spinout-spark-once-402m-stock-sale.html?ana=yahoo&yptr=yahoo&.tsrc=rss,"Spark Therapeutics Inc. closed its previously announced $402 million public stock offering.  The Philadelphia gene therapy company sold 5.3 million shares of common stock at $76 per share.  Spark (ONCE) plans to use its $380.4 million in net proceeds from offering principally for ""the continuation and initiation of further clinical trials, commercialization, manufacturing, business development activities, including the potential licensing or acquisition of complementary products and technologies,” according to the company’s filing with the Securities and Exchange Commission."
ONCE,ONCE:UW,BBG007TJWN87,"IHS Markit Score downgrades Spark Therapeutics Inc to 24 out of 100, ranking positively in only one out of three available IHS Markit categories.",2017-08-10 12:03:27 +0000,https://finance.yahoo.com/news/ihs-markit-score-downgrades-spark-120327683.html?.tsrc=rss,Spark Therapeutics Inc NASDAQ/NGS:ONCE
ONCE,ONCE:UW,BBG007TJWN87,Spark Therapeutics Announces Closing of Public Offering,2017-08-09 20:05:00 +0000,https://finance.yahoo.com/news/spark-therapeutics-announces-closing-public-200500847.html?.tsrc=rss,"PHILADELPHIA, Aug. 09, 2017-- Spark Therapeutics, Inc. announced today the closing of the previously announced underwritten public offering of its common stock pursuant to an automatically effective shelf ..."
ONCE,ONCE:UW,BBG007TJWN87,See what the IHS Markit Score report has to say about Spark Therapeutics Inc.,2017-08-09 12:03:24 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120324374.html?.tsrc=rss,"The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.  Index (PMI) data, output in the Healthcare sector is rising."
ONCE,ONCE:UW,BBG007TJWN87,Featured Company News – Athersys Reported Alignment of Key Regulators for Pivotal Registration Study in Ischemic Stroke,2017-08-09 11:30:00 +0000,https://finance.yahoo.com/news/featured-company-news-athersys-reported-113000285.html?.tsrc=rss,"Research Desk Line-up: Spark Therapeutics Post Earnings Coverage LONDON, UK / ACCESSWIRE / August 9, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines for ..."
ONCE,ONCE:UW,BBG007TJWN87,Drugmakers' hopes for gene therapy rise despite tiny sales in Europe,2017-08-08 10:17:48 +0000,https://finance.yahoo.com/news/drugmakers-hopes-gene-therapy-rise-101748104.html?.tsrc=rss,"The science of gene therapy is  finally delivering on its potential, and drugmakers are now  hoping to produce commercially viable medicines after tiny sales  for the first two such treatments in Europe.  After decades of frustrations, firms believe there are now  major opportunities for gene therapy in treating inherited  conditions such as haemophilia."
ONCE,ONCE:UW,BBG007TJWN87,Why You Shouldn't Fear Spark Therapeutics' Upcoming Share Issue,2017-08-07 13:39:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ScexREC4nxc/why-you-shouldnt-fear-spark-therapeutics-upcoming-share-issue-cm827930,Having your shares in a company heavily diluted by a big secondary share issue is often scary for investors It s easy to see why if a company dumps a bucket of new stock on the market existing shareholders slice of the pie gets smaller Their piece of the business is reduced by
ONCE,ONCE:UW,BBG007TJWN87,Why You Shouldn&apos;t Fear Spark Therapeutics&apos; Upcoming Share Issue,2017-08-07 11:44:00 +0000,http://finance.yahoo.com/r/e4634d2c-3cdd-3792-8809-815d903f802b/why-you-shouldnt-fear-spark-therapeutics-upcoming.aspx?yptr=yahoo&.tsrc=rss,Spark Therapeutics is about to float $350 million worth of its own stock.
ONCE,ONCE:UW,BBG007TJWN87,Spark Therapeutics Prices Offering At $76/Share,2017-08-04 07:47:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/SLMlMziFI24/spark-therapeutics-prices-offering-at-76share-20170804-00387,Spark Therapeutics Prices Offering At $76/Share
ONCE,ONCE:UW,BBG007TJWN87,Spark Therapeutics Announces Pricing of $350.0 Million Public Offering,2017-08-03 23:19:34 +0000,https://finance.yahoo.com/news/spark-therapeutics-announces-pricing-350-231934259.html?.tsrc=rss,"PHILADELPHIA, Aug. 03, 2017-- Spark Therapeutics, Inc. announced today the pricing of an underwritten public offering of 4,605,264 shares of its common stock pursuant to an automatically effective shelf ..."
ONCE,ONCE:UW,BBG007TJWN87,Today's Research Reports on Stocks to Watch: Marinus Pharmaceuticals and Sparks Therapeutics,2017-08-03 12:10:00 +0000,https://finance.yahoo.com/news/todays-research-reports-stocks-watch-121000549.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / August 3, 2017 / Marinus Pharmaceuticals may have reported a loss in its second quarter, but traders may have been encouraged by the company's business update about a phase ..."
ONCE,ONCE:UW,BBG007TJWN87,Spark Therapeutics reports 2Q loss,2017-08-03 02:50:39 +0000,https://finance.yahoo.com/news/spark-therapeutics-reports-2q-loss-114251359.html?.tsrc=rss,"On a per-share basis, the Philadelphia-based company said it had a loss of $2.40. Losses, adjusted for asset impairment costs, came to $1.89 per share. The results fell short of Wall Street expectations. ..."
ONCE,ONCE:UW,BBG007TJWN87,"Gainers & Losers Of Aug.2: ONCE, ILMN, XENT, NOVN, FLKS...",2017-08-02 22:00:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9F0Ot6PnVn8/gainers--losers-of-aug2-once-ilmn-xent-novn-flks-20170802-02061,"Gainers & Losers Of Aug.2: ONCE, ILMN, XENT, NOVN, FLKS..."
ONCE,ONCE:UW,BBG007TJWN87,Spark Therapeutics Announces Proposed Public Offering of Common Stock,2017-08-02 21:04:57 +0000,https://finance.yahoo.com/news/spark-therapeutics-announces-proposed-public-210457844.html?.tsrc=rss,"PHILADELPHIA, Aug. 02, 2017-- Spark Therapeutics, Inc. announced today that it has commenced an underwritten public offering of $300,000,000 in shares of its common stock. Spark also intends to grant the ..."
ONCE,ONCE:UW,BBG007TJWN87,"Health Care Sector Update for 08/02/2017: OCUL,ONCE,COTV",2017-08-02 20:34:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/gwJay4SeGnU/health-care-sector-update-for-08022017-oculoncecotv-cm826062,HEALTHCARE HEALTHCARE JNJ 0 43 JNJ 0 43 PFE 0 11 PFE 0 11 ABT 0 06 ABT 0 06 MRK 0 94 MRK 0 94 AMGN 0 15 AMGN 0 15 Health care stocks resumed their declines this afternoon with the NYSE Health Care Index putting up a 0 3 retreat while shares of health care companies in
ONCE,ONCE:UW,BBG007TJWN87,How These 2 Biotechs Defied The Downtrend To Hit Fresh Highs,2017-08-02 20:21:07 +0000,http://finance.yahoo.com/r/db040190-9559-3152-9ffe-f86787133ada/how-these-2-biotechs-defied-the-downtrend-to-hit-fresh-highs?src=A00220&yptr=yahoo&.tsrc=rss,Spark and Corcept defied a downtrend in the biotech sector Wednesday and instead rocketed to fresh highs on strong second-quarter reports.
ONCE,ONCE:UW,BBG007TJWN87,Here's Why Spark Therapeutics Inc. Is Soaring Today,2017-08-02 18:57:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/e-sGwt7A6iY/heres-why-spark-therapeutics-inc-is-soaring-today-cm825971,What Happened After reporting second quarter results that contained upbeat clinical news 160 Spark Therapeutics NASDAQ ONCE a clinical stage company focused on gene therapy rose 18 as of 12 30 p m EDT on Wednesday So what Here s a review of the key highlights from
ONCE,ONCE:UW,BBG007TJWN87,"Health Care Sector Update for 08/02/2017: CORT,ONCE,COTV",2017-08-02 18:56:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1OiwyOxkxZY/health-care-sector-update-for-08022017-cortoncecotv-cm825997,Top Health Care StocksTop Health Care Stocks JNJ 0 47 JNJ 0 47 PFE 0 12 PFE 0 12 ABT 0 07 ABT 0 07 MRK 0 84 MRK 0 84 AMGN 0 12 AMGN 0 12 Health care stocks were trimming some of their losses this afternoon with the NYSE Health Care Index sliding to a 0 2 decline while shares
ONCE,ONCE:UW,BBG007TJWN87,Here&apos;s Why Spark Therapeutics Inc. Is Soaring Today,2017-08-02 17:05:00 +0000,http://finance.yahoo.com/r/033d5958-167c-34d6-bc08-8b38a7b1fb01/heres-why-spark-therapeutics-inc-is-soaring-today.aspx?yptr=yahoo&.tsrc=rss,Upbeat clinical news released in the company&apos;s second-quarter earnings report has traders feeling good today.
ONCE,ONCE:UW,BBG007TJWN87,"Illumina Shares Spike on Strong Earnings, Upside Still Remains: Biotech Movers",2017-08-02 15:17:00 +0000,http://finance.yahoo.com/r/a57b08d6-5703-31e5-8be6-1b0d6f95b3b6/illumina-shares-spike-on-strong-earnings-upside-still-remains-biotech-movers.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Illumina, Spark Therapeutics and Endo International were among the biotech stock movers in premarket trading on Aug. 2."
ONCE,ONCE:UW,BBG007TJWN87,Spark Therapeutics Reports Second Quarter 2017 Financial Results and Recent Business Progress,2017-08-02 11:30:00 +0000,https://finance.yahoo.com/news/spark-therapeutics-reports-second-quarter-113000737.html?.tsrc=rss,"Preliminary interim data for SPK-8011 Phase 1/ 2 dose-escalation clinical trial in hemophilia A show initial human proof-of-concept in three participants. In the two participants at the initial dose, stable ..."
ONCE,ONCE:UW,BBG007TJWN87,InPlay from Briefing.com,2017-07-31 11:58:05 +0000,https://finance.yahoo.com/news/inplay-briefing-com-125529772.html?.tsrc=rss,InPlay from Briefing.com
ONCE,ONCE:UW,BBG007TJWN87,Spark Therapeutics Submits Marketing Authorization Application to European Medicines Agency for Investigational LUXTURNA(TM) (voretigene neparvovec),2017-07-31 11:31:01 +0000,https://finance.yahoo.com/news/spark-therapeutics-submits-marketing-authorization-113101360.html?.tsrc=rss,"Potential for first gene therapy for a genetic disease to be approved in both the U.S. and EU PHILADELPHIA, July 31, 2017 (GLOBE NEWSWIRE) -- Spark Therapeutics (NASDAQ:ONCE), a fully integrated gene therapy ..."
ONCE,ONCE:UW,BBG007TJWN87,Spark Therapeutics Submits Marketing Authorization Application to European Medicines Agency for Investigational LUXTURNA™ (voretigene neparvovec),2017-07-31 11:30:00 +0000,https://finance.yahoo.com/news/spark-therapeutics-submits-marketing-authorization-113000000.html?.tsrc=rss,"PHILADELPHIA, July 31, 2017-- Spark Therapeutics, a fully integrated gene therapy company dedicated to challenging the inevitability of genetic disease, announced today that it has submitted a Marketing ..."
ONCE,ONCE:UW,BBG007TJWN87,Company Spotlight: Spark Therapeutics,2017-07-29 23:32:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/vVOhVTN9JY8/company-spotlight-spark-therapeutics-20170729-00008,Company Spotlight: Spark Therapeutics
ONCE,ONCE:UW,BBG007TJWN87,"Spark Therapeutics to Host Conference Call on Wednesday, Aug. 2 at 8:30 a.m. ET to Discuss Second Quarter 2017 Results",2017-07-28 11:30:00 +0000,https://finance.yahoo.com/news/spark-therapeutics-host-conference-call-113000403.html?.tsrc=rss,"PHILADELPHIA, July 28, 2017-- Spark Therapeutics, a fully integrated gene therapy company dedicated to challenging the inevitability of genetic disease, will host a conference call on Wednesday, Aug. 2, ..."
ONCE,ONCE:UW,BBG007TJWN87,Spark Therapeutics (ONCE) Worth a Look: Stock Gains 5.7%,2017-07-24 13:04:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pkYkSOvnRNQ/spark-therapeutics-once-worth-a-look-stock-gains-57-cm819998,Spark Therapeutics Inc ONCE was a big mover last session as the company saw its shares rise above 5 on the day The move came on solid volume too with far more shares changing hands than in a normal session This breaks the recent trend for the company as the stock is now trading above
ONCE,ONCE:UW,BBG007TJWN87,Spark Therapeutics (ONCE) Worth a Look: Stock Gains 5.7%,2017-07-24 12:20:12 +0000,https://finance.yahoo.com/news/spark-therapeutics-once-worth-look-122012035.html?.tsrc=rss,"Spark Therapeutics, Inc. (ONCE) shares rose above 5% in the last trading session."
ONCE,ONCE:UW,BBG007TJWN87,Spark Therapeutics Receives Rare Pediatric Disease Designation for Investigational LUXTURNA™ (voretigene neparvovec) from FDA,2017-07-20 11:30:00 +0000,https://finance.yahoo.com/news/spark-therapeutics-receives-rare-pediatric-113000259.html?.tsrc=rss,"PHILADELPHIA, July 20, 2017-- Spark Therapeutics, a fully integrated gene therapy company dedicated to challenging the inevitability of genetic disease, announced today that the Offices of Orphan Products ..."
ONCE,ONCE:UW,BBG007TJWN87,"FDA Nod For PBYI, ANIK Sees 23-26% Revenue Growth, CBAY Abuzz, RPRX Plunges",2017-07-18 03:42:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ehAY7mKbIFs/fda-nod-for-pbyi-anik-sees-2326-revenue-growth-cbay-abuzz-rprx-plunges-20170718-00099,"FDA Nod For PBYI, ANIK Sees 23-26% Revenue Growth, CBAY Abuzz, RPRX Plunges"
ONCE,ONCE:UW,BBG007TJWN87,"FDA Nod For PBYI, ANIK Sees 23-26% Revenue Growth, CBAY Abuzz, RPRX Plunges",2017-07-18 03:42:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/d6iX_VkeCJo/fda-nod-for-pbyi-anik-sees-2326%25-revenue-growth-cbay-abuzz-rprx-plunges-20170718-00099,"FDA Nod For PBYI, ANIK Sees 23-26% Revenue Growth, CBAY Abuzz, RPRX Plunges"
ONCE,ONCE:UW,BBG007TJWN87,Spark Therapeutics’ Biologics License Application for Investigational Voretigene Neparvovec Accepted for Filing by FDA,2017-07-17 11:30:00 +0000,https://finance.yahoo.com/news/spark-therapeutics-biologics-license-application-113000131.html?.tsrc=rss,"FDA grants Priority Review with Prescription Drug User Fee Act date of Jan. 12, 2018. LUXTURNA TM unveiled as proposed trade name. PHILADELPHIA, July 17, 2017-- Spark Therapeutics, a fully integrated gene ..."
ONCE,ONCE:UW,BBG007TJWN87,These Are the Best Growth Stocks Right Now in Biotech,2017-07-14 20:11:00 +0000,http://finance.yahoo.com/r/ff21db70-042b-37f6-be12-270c76816cda/celgene-vertex-and-spark-among-jefferies-top-biotech-picks.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Top names.
ONCE,ONCE:UW,BBG007TJWN87,Spark Therapeutics Announces Publication in The Lancet of Pivotal Phase 3 Clinical Trial Data for Investigational Voretigene Neparvovec,2017-07-13 22:30:00 +0000,https://finance.yahoo.com/news/spark-therapeutics-announces-publication-lancet-223000761.html?.tsrc=rss,"PHILADELPHIA, July 13, 2017-- Spark Therapeutics, a fully integrated gene therapy company dedicated to challenging the inevitability of genetic disease, today announced The Lancet, a highly ranked peer-reviewed ..."
ONCE,ONCE:UW,BBG007TJWN87,Implied Volatility Surging for Spark Therapeutics (ONCE) Stock Options,2017-07-11 14:50:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8U2elY0d3y4/implied-volatility-surging-for-spark-therapeutics-once-stock-options-cm814365,Investors in Spark Therapeutics Inc ONCE need to pay close attention to the stock based on moves in the options market lately That is because the July 21 2017 60 Call had some of the highest implied volatility of all equity options today What is Implied Volatility Implied
ONCE,ONCE:UW,BBG007TJWN87,Implied Volatility Surging for Spark Therapeutics (ONCE) Stock Options,2017-07-11 12:46:12 +0000,https://finance.yahoo.com/news/implied-volatility-surging-spark-therapeutics-124612078.html?.tsrc=rss,"Investors in Spark Therapeutics, Inc. (ONCE) need to pay close attention to the stock based on moves in the options market lately."
ONCE,ONCE:UW,BBG007TJWN87,"ETFs with exposure to Spark Therapeutics, Inc. : July 10, 2017",2017-07-10 19:00:27 +0000,http://finance.yahoo.com/r/67a3f714-f1a5-3aac-9ff1-6384c4f0d3c0/etfs-with-exposure-to-spark-therapeutics-inc-july-10-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Spark Therapeutics, Inc. Here are 5 ETFs with the largest exposure to ONCE-US. Comparing the performance and risk of Spark Therapeutics, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more
<b>(Read more...)</b>"
ONCE,ONCE:UW,BBG007TJWN87,Spark Therapeutics Presents Updated Interim Hemophilia B Data Supporting Consistent and Sustained Response at the International Society on Thrombosis and Haemostasis (ISTH) 2017 Congress,2017-07-10 15:47:43 +0000,https://finance.yahoo.com/news/spark-therapeutics-presents-updated-interim-154743520.html?.tsrc=rss,"Data demonstrate a 99- percent reduction in annualized infusion rate and a 96- percent reduction in annualized bleeding rate in 10 participants as of June 5, 2017. Five trial participants are now at least ..."
ONCE,ONCE:UW,BBG007TJWN87,A Barrage Of Biotech Updates Expected At ISTH Meeting,2017-07-07 21:08:01 +0000,https://finance.yahoo.com/news/barrage-biotech-updates-expected-isth-210801883.html?.tsrc=rss,"Biotech stocks are highly volatile investments, which look toward catalytic events such as FDA decisions, clinical trial results and data presentation at various conferences. Benzinga has compiled a list ..."
ONCE,ONCE:UW,BBG007TJWN87,"Gainers & Losers Of July 5: CALA, NVRO, BPMC, KMPH, FLDM...",2017-07-05 22:05:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-sOasuVpC4g/gainers--losers-of-july-5-cala-nvro-bpmc-kmph-fldm-20170705-01206,"Gainers & Losers Of July 5: CALA, NVRO, BPMC, KMPH, FLDM..."
ONCE,ONCE:UW,BBG007TJWN87,Spark Therapeutics to Present Updated Hemophilia B Data at the International Society on Thrombosis and Haemostasis (ISTH) 2017 Congress,2017-06-23 06:00:00 +0000,https://finance.yahoo.com/news/spark-therapeutics-present-updated-hemophilia-060000857.html?.tsrc=rss,"PHILADELPHIA, June 23, 2017-- Spark Therapeutics, a fully integrated gene therapy company dedicated to challenging the inevitability of genetic disease, announced today that Lindsey George, M.D., attending ..."
ONCE,ONCE:UW,BBG007TJWN87,"ETFs with exposure to Spark Therapeutics, Inc. : June 15, 2017",2017-06-15 18:52:00 +0000,http://finance.yahoo.com/r/cfe5888d-7475-38cf-82d8-fbc79b086747/etfs-with-exposure-to-spark-therapeutics-inc-june-15-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Spark Therapeutics, Inc. Here are 5 ETFs with the largest exposure to ONCE-US. Comparing the performance and risk of Spark Therapeutics, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more
<b>(Read more...)</b>"
ONCE,ONCE:UW,BBG007TJWN87,"Spark Therapeutics, Inc. breached its 50 day moving average in a Bearish Manner : ONCE-US : June 9, 2017",2017-06-09 12:48:54 +0000,http://finance.yahoo.com/r/9efb659e-db10-35d7-bf3f-3c21a5c70e3b/spark-therapeutics-inc-breached-its-50-day-moving-average-in-a-bearish-manner-once-us-june-9-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Spark Therapeutics, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bearish ... Read more
<b>(Read more...)</b>"
ONCE,ONCE:UW,BBG007TJWN87,Spark Therapeutics to Participate in Multiple Conferences in June,2017-06-01 11:30:00 +0000,https://finance.yahoo.com/news/spark-therapeutics-participate-multiple-conferences-113000341.html?.tsrc=rss,"PHILADELPHIA, June 01, 2017-- Spark Therapeutics, a fully integrated gene therapy company dedicated to challenging the inevitability of genetic disease, today announced that company management will present ..."
ONCE,ONCE:UW,BBG007TJWN87,"Spark Therapeutics, Inc. breached its 50 day moving average in a Bearish Manner : ONCE-US : May 29, 2017",2017-05-29 12:22:05 +0000,http://finance.yahoo.com/r/8727e80c-2b52-3257-b72c-66b6acd423e7/spark-therapeutics-inc-breached-its-50-day-moving-average-in-a-bearish-manner-once-us-may-29-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Spark Therapeutics, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving ... Read more
<b>(Read more...)</b>"
ONCE,ONCE:UW,BBG007TJWN87,"ETFs with exposure to Spark Therapeutics, Inc. : May 25, 2017",2017-05-25 16:45:31 +0000,http://finance.yahoo.com/r/05ce8a05-373f-3384-a04f-38fcd4139f7a/etfs-with-exposure-to-spark-therapeutics-inc-may-25-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Spark Therapeutics, Inc. Here are 5 ETFs with the largest exposure to ONCE-US. Comparing the performance and risk of Spark Therapeutics, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more
<b>(Read more...)</b>"
ONCE,ONCE:UW,BBG007TJWN87,"Spark Therapeutics, Inc. :ONCE-US: Earnings Analysis: Q1, 2017 By the Numbers : May 24, 2017",2017-05-24 14:22:47 +0000,http://finance.yahoo.com/r/be6f49ee-49e7-3a67-b4f3-1fb6be809f1b/spark-therapeutics-inc-once-us-earnings-analysis-q1-2017-by-the-numbers-may-24-2017?yptr=yahoo&.tsrc=rss,"Categories:  Yahoo FinanceGet free summary analysis Spark Therapeutics, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Spark Therapeutics, Inc. – Immunomedics, Inc., Harvard Bioscience, Inc., FibroGen, Inc. and Illumina, Inc. (IMMU-US, HBIO-US, FGEN-US and ILMN-US) that have also reported for this period. Highlights Summary ... Read more
<b>(Read more...)</b>"
ONCE,ONCE:UW,BBG007TJWN87,Spark completes FDA application for gene therapy candidate to repair vision loss,2017-05-18 13:40:12 +0000,http://finance.yahoo.com/r/fe13699e-8559-30e6-b0f9-cac577d6120e/spark-completes-fda-application-for-gene-therapy.html?ana=yahoo&yptr=yahoo&.tsrc=rss,"Spark Therapeutics said Thursday it has completed its rolling submission of its biologics license application for its lead gene therapy candidate, voretigene neparvovec, with the Food and Drug Administration.  If approved, voretigene neparvovec is in position to become the first gene therapy in the United States for a genetic disease.  Spark (ONCE), a company spun out of Children’s Hospital of Philadelphia, is developing the gene therapy as a one-time treatment for patients with vision loss caused by a rare condition described as “confirmed biallelic RPE65 mutation-associated retinal disease.” Patients with the condition typically experience vision loss at an early age."
ONCE,ONCE:UW,BBG007TJWN87,"Spark Therapeutics, Inc. breached its 50 day moving average in a Bearish Manner : ONCE-US : May 18, 2017",2017-05-18 12:38:47 +0000,http://finance.yahoo.com/r/99d93efe-12b1-31a0-9045-2493236b84e5/spark-therapeutics-inc-breached-its-50-day-moving-average-in-a-bearish-manner-once-us-may-18-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Spark Therapeutics, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving ... Read more
<b>(Read more...)</b>"
ONCE,ONCE:UW,BBG007TJWN87,Spark Therapeutics Completes Rolling Biologics License Application Submission to FDA for Investigational Gene Therapy Voretigene Neparvovec,2017-05-18 11:30:00 +0000,https://finance.yahoo.com/news/spark-therapeutics-completes-rolling-biologics-113000244.html?.tsrc=rss,"PHILADELPHIA, May 18, 2017-- Spark Therapeutics, a fully integrated gene therapy company dedicated to challenging the inevitability of genetic disease, today announced the completion of the rolling submission ..."
ONCE,ONCE:UW,BBG007TJWN87,Edited Transcript of ONCE earnings conference call or presentation 9-May-17 12:30pm GMT,2017-05-15 19:10:38 +0000,https://finance.yahoo.com/news/edited-transcript-once-earnings-conference-180046055.html?.tsrc=rss,Q1 2017 Spark Therapeutics Inc Earnings Call
ONCE,ONCE:UW,BBG007TJWN87,"Commit To Purchase Spark Therapeutics At $50, Earn 25.9% Annualized Using Options",2017-05-11 17:01:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dBoYC7Js-qU/commit-to-purchase-spark-therapeutics-at-50-earn-259-annualized-using-options-cm787970,Investors considering a purchase of Spark Therapeutics Inc Symbol ONCE shares but tentative about paying the going market price of 58 44 share might benefit from considering selling puts among the alternative strategies at their disposal One interesting put contract in particular is
ONCE,ONCE:UW,BBG007TJWN87,Edited Transcript of ONCE earnings conference call or presentation 9-May-17 12:30pm GMT,2017-05-11 01:10:48 +0000,http://finance.yahoo.com/news/edited-transcript-once-earnings-conference-180046055.html?.tsrc=rss,Q1 2017 Spark Therapeutics Inc Earnings Call
ONCE,ONCE:UW,BBG007TJWN87,Spark Therapeutics reports 1Q loss,2017-05-09 11:49:54 +0000,http://finance.yahoo.com/news/spark-therapeutics-reports-1q-loss-114954365.html?.tsrc=rss,"On a per-share basis, the Philadelphia-based company said it had a loss of $1.70. The results fell short of Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research ..."
ONCE,ONCE:UW,BBG007TJWN87,Spark Therapeutics Reports First Quarter 2017 Financial Results and Recent Business Progress,2017-05-09 11:30:00 +0000,http://finance.yahoo.com/news/spark-therapeutics-reports-first-quarter-113000668.html?.tsrc=rss,Biologics License Application for investigational voretigene neparvovec is complete. Interim results from SPK-7001 Phase 1/ 2 clinical trial in choroideremia reported; continuing enrollment targeting participants ...
ONCE,ONCE:UW,BBG007TJWN87,Spark Therapeutics to Participate in Multiple Meetings in May,2017-05-03 11:30:00 +0000,http://finance.yahoo.com/news/spark-therapeutics-participate-multiple-meetings-113000930.html?.tsrc=rss,"PHILADELPHIA, May 03, 2017-- Spark Therapeutics, a fully integrated gene therapy company dedicated to challenging the inevitability of genetic disease, announced today that members of company management ..."
ONCE,ONCE:UW,BBG007TJWN87,"Spark Therapeutics to Host Conference Call on Tuesday, May 9 at 8:30 a.m. to Discuss Q1 2017 Results",2017-05-02 11:30:00 +0000,http://finance.yahoo.com/news/spark-therapeutics-host-conference-call-113000373.html?.tsrc=rss,"PHILADELPHIA, May 02, 2017-- Spark Therapeutics, a fully integrated gene therapy company dedicated to challenging the inevitability of genetic disease, will host a conference call on Tuesday, May 9, 2017, ..."
ONCE,ONCE:UW,BBG007TJWN87,"Spark Therapeutics, Inc. – Value Analysis (NASDAQ:ONCE) : April 27, 2017",2017-04-27 21:04:53 +0000,http://finance.yahoo.com/r/04e93dff-ee67-3068-910b-df2d85d2b8b4/spark-therapeutics-inc-value-analysis-nasdaqonce-april-27-2017?yptr=yahoo&.tsrc=rss,"Categories:  Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Spark Therapeutics, Inc. a score of 17. Our analysis is based on comparing Spark Therapeutics, Inc. with the following peers – Immunomedics, Inc., Harvard Bioscience, Inc., FibroGen, Inc. and Illumina, Inc. (IMMU-US, HBIO-US, FGEN-US and ILMN-US). Investment Outlook Spark Therapeutics, Inc. has a fundamental score of 17 ... Read more
<b>(Read more...)</b>"
ONCE,ONCE:UW,BBG007TJWN87,"Spark Therapeutics, Inc. breached its 50 day moving average in a Bullish Manner : ONCE-US : April 26, 2017",2017-04-26 12:39:24 +0000,http://finance.yahoo.com/r/be3141fe-57c9-31b8-8146-abcebe6caa4b/spark-therapeutics-inc-breached-its-50-day-moving-average-in-a-bullish-manner-once-us-april-26-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Spark Therapeutics, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving ... Read more
<b>(Read more...)</b>"
ONCE,ONCE:UW,BBG007TJWN87,"Sofinnova Management VIII, L.L.C. Buys ObsEva SA, Auris Medical Holding AG, Sells Aclaris ...",2017-04-11 22:53:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QTJYGhph0J8/sofinnova-management-viii-llc-buys-obseva-sa-auris-medical-holding-ag-sells-aclaris-cm773001,Sofinnova Management VIII L L C New Purchases OBSV Added Positions EARS Reduced Positions ACRS VSAR ONCE New Purchases OBSV New Purchases OBSV Added Positions EARS Added Positions EARS Reduced Positions
ONCE,ONCE:UW,BBG007TJWN87,Mystery Clot Reveals a Helpful Mutant Gene in Hunt for a Cure,2017-04-11 09:00:00 +0000,http://finance.yahoo.com/r/2b693e6d-38d4-3fd6-b1dd-b8d880f8795e/mystery-clot-reveals-a-helpful-mutant-gene-in-hunt-for-a-cure?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss,"When he first saw the results from his 23-year-old patient with a painful leg clot, Paolo Simioni assumed the test was botched and angrily told his lab technician repeat it. But the number came back the ..."
ONCE,ONCE:UW,BBG007TJWN87,"ETFs with exposure to Spark Therapeutics, Inc. : April 7, 2017",2017-04-07 21:13:35 +0000,http://finance.yahoo.com/r/035fda89-d2f6-37ff-b590-12ae3aba024c/etfs-with-exposure-to-spark-therapeutics-inc-april-7-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Spark Therapeutics, Inc. Here are 5 ETFs with the largest exposure to ONCE-US. Comparing the performance and risk of Spark Therapeutics, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more
<b>(Read more...)</b>"
ONCE,ONCE:UW,BBG007TJWN87,Spark Therapeutics Presents Updated Preliminary Data from Hemophilia B Phase 1/2 Trial Suggesting Consistent and Sustained Levels of Factor IX Activity at the Hemostasis and Thrombosis Research Society (HTRS) 2017 Scientific Symposium,2017-04-06 11:30:00 +0000,http://finance.yahoo.com/news/spark-therapeutics-presents-updated-preliminary-113000892.html?.tsrc=rss,"As of data cutoff, the annualized bleeding rate has been reduced by 96 percent and the annualized infusion rate reduced by 99 percent. Both participants who began a tapering course of steroids have completed ..."
ONCE,ONCE:UW,BBG007TJWN87,Just How Much Is a Medical Miracle Worth?,2017-04-06 09:00:15 +0000,http://finance.yahoo.com/news/just-much-medical-miracle-worth-090015067.html?.tsrc=rss,Years of costly treatments could give way to pricier one-shot cures like Spark Therapeutics’ blindness drug. But insurers aren’t ready.
ONCE,ONCE:UW,BBG007TJWN87,"INNL To Be Acquired, ELGX Seeks Funds, Opdivo At FDA Altar Again, NLNK Abuzz",2017-04-05 02:28:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VS2wOGG0bXo/innl-to-be-acquired-elgx-seeks-funds-opdivo-at-fda-altar-again-nlnk-abuzz-20170405-00066,"INNL To Be Acquired, ELGX Seeks Funds, Opdivo At FDA Altar Again, NLNK Abuzz"
ONCE,ONCE:UW,BBG007TJWN87,Spark Therapeutics to Present Updated Hemophilia B Data at the Hemostasis and Thrombosis Research Society (HTRS) 2017 Scientific Symposium,2017-04-04 20:15:00 +0000,http://finance.yahoo.com/news/spark-therapeutics-present-updated-hemophilia-201500118.html?.tsrc=rss,"PHILADELPHIA, April 04, 2017-- Spark Therapeutics, a fully integrated gene therapy company dedicated to challenging the inevitability of genetic disease, announced today that Adam Cuker, M.D., assistant ..."
ONCE,ONCE:UW,BBG007TJWN87,Coverage initiated on Spark Therapeutics by UBS,2017-03-30 13:23:32 +0000,http://finance.yahoo.com/q/ud?s=ONCE,Coverage initiated on Spark Therapeutics by UBS
ONCE,ONCE:UW,BBG007TJWN87,"ETFs with exposure to Spark Therapeutics, Inc. : March 27, 2017",2017-03-27 20:02:31 +0000,http://finance.yahoo.com/r/b59c8653-a759-3919-b9b7-fa92d241053c/etfs-with-exposure-to-spark-therapeutics-inc-march-27-2017?yptr=yahoo&.tsrc=rss,"Categories:   ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to Spark Therapeutics, Inc. Here are 5 ETFs with the largest exposure to ONCE-US. Comparing the performance and risk of Spark Therapeutics, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more    
<b>(Read more...)</b>"
ONCE,ONCE:UW,BBG007TJWN87,"ETFs with exposure to Spark Therapeutics, Inc. : March 27, 2017",2017-03-27 20:02:31 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-spark-therapeutics-inc-march-27-2017/,"ETFs with exposure to Spark Therapeutics, Inc. : March 27, 2017"
ONCE,ONCE:UW,BBG007TJWN87,Spark Therapeutics is Now Oversold (ONCE),2017-03-21 22:07:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/G4oqGFPzNGs/spark-therapeutics-is-now-oversold-once-cm763809,Legendary investor Warren Buffett advises to be fearful when others are greedy and be greedy when others are fearful One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index or RSI which measures momentum on
ONCE,ONCE:UW,BBG007TJWN87,"Spark Therapeutics, Inc. :ONCE-US: Earnings Analysis: Q4, 2016 By the Numbers : March 20, 2017",2017-03-20 16:03:12 +0000,http://www.capitalcube.com/blog/index.php/spark-therapeutics-inc-once-us-earnings-analysis-q4-2016-by-the-numbers-march-20-2017/,"Spark Therapeutics, Inc. :ONCE-US: Earnings Analysis: Q4, 2016 By the Numbers : March 20, 2017"
ONCE,ONCE:UW,BBG007TJWN87,"Spark Therapeutics, Inc. :ONCE-US: Earnings Analysis: Q4, 2016 By the Numbers : March 20, 2017",2017-03-20 16:03:12 +0000,http://finance.yahoo.com/r/40b77411-8622-39fc-9387-89dcd2f49c87/spark-therapeutics-inc-once-us-earnings-analysis-q4-2016-by-the-numbers-march-20-2017?yptr=yahoo&.tsrc=rss,"Categories:   Yahoo Finance Get free summary analysis Spark Therapeutics, Inc. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of Spark Therapeutics, Inc. – Immunomedics, Inc., Harvard Bioscience, Inc., FibroGen, Inc. and Illumina, Inc. (IMMU-US, HBIO-US, FGEN-US and ILMN-US) that have also reported for this period. Highlights Summary ... Read more    
<b>(Read more...)</b>"
ONCE,ONCE:UW,BBG007TJWN87,3 Biotech Stocks to Buy in March,2017-03-11 00:18:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KwMCTFA5GVg/3-biotech-stocks-to-buy-in-march-cm759560,Which biotech stocks look like smart picks right now 160 That s the question we posed to three of The Motley Fool s healthcare contributors All three answered with small cap biotech stocks Spark Therapeutics NASDAQ ONCE Albany Molecular Research NASDAQ AMRI
ONCE,ONCE:UW,BBG007TJWN87,ONCE Makes Notable Cross Below Critical Moving Average,2017-03-11 00:13:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/K0nsubfU8Y4/once-makes-notable-cross-below-critical-moving-average-cm759409,In trading on Friday shares of Spark Therapeutics Inc Symbol ONCE crossed below their 200 day moving average of 56 18 changing hands as low as 55 66 per share Spark Therapeutics Inc shares are currently trading off about 1 9 on the day The chart below shows the one year performance
ONCE,ONCE:UW,BBG007TJWN87,3 Biotech Stocks to Buy in March,2017-03-10 17:07:00 +0000,http://finance.yahoo.com/r/3b50d091-b5cc-34d4-9d90-68e263a00343/3-biotech-stocks-to-buy-in-march.aspx?yptr=yahoo&.tsrc=rss,"Why Spark Therapeutics, Albany Molecular Research, and Concert Pharmaceuticals could be great biotech stocks to buy as spring approaches."
ONCE,ONCE:UW,BBG007TJWN87,3 Biotech Stocks to Buy in March,2017-03-10 17:07:00 +0000,http://www.fool.com/investing/2017/03/10/3-biotech-stocks-to-buy-in-march.aspx,3 Biotech Stocks to Buy in March
ONCE,ONCE:UW,BBG007TJWN87,"SPARK THERAPEUTICS, INC. Financials",2017-03-04 18:04:14 +0000,http://finance.yahoo.com/q/is?s=once,"SPARK THERAPEUTICS, INC. Financials"
ONCE,ONCE:UW,BBG007TJWN87,5 Small-Cap Biotech Stocks to Buy in March,2017-03-02 14:22:00 +0000,http://www.fool.com/investing/2017/03/02/5-small-cap-biotech-stocks-to-buy-in-march.aspx,5 Small-Cap Biotech Stocks to Buy in March
ONCE,ONCE:UW,BBG007TJWN87,5 Small-Cap Biotech Stocks to Buy in March,2017-03-02 14:22:00 +0000,http://finance.yahoo.com/r/9537c74b-0aa6-392c-924d-9c0720f80ed0/5-small-cap-biotech-stocks-to-buy-in-march.aspx?yptr=yahoo&.tsrc=rss,"Why small-cap biotech stocks Coherus BioSciences, Halozyme Therapeutics, PTC Therapeutics, Radius Health, and Spark Therapeutics could soar."
ONCE,ONCE:UW,BBG007TJWN87,Spark Therapeutics to Participate in Multiple Conferences in March,2017-03-02 12:30:00 +0000,http://finance.yahoo.com/news/spark-therapeutics-participate-multiple-conferences-123000099.html?.tsrc=rss,"PHILADELPHIA, March 02, 2017-- Spark Therapeutics, a fully integrated gene therapy company dedicated to challenging the inevitability of genetic disease, announced today that Jeffrey D. Marrazzo, chief ..."
ONCE,ONCE:UW,BBG007TJWN87,Spark Therapeutics to Participate in Multiple Conferences in March,2017-03-02 12:30:00 +0000,http://finance.yahoo.com/news/spark-therapeutics-participate-multiple-conferences-123000099.html,"[GlobeNewswire] - PHILADELPHIA, March 02, 2017-- Spark Therapeutics, a fully integrated gene therapy company dedicated to challenging the inevitability of genetic disease, announced today that Jeffrey D. Marrazzo, chief ..."
ONCE,ONCE:UW,BBG007TJWN87,"4:16 pm Spark Therapeutics and Pfizer (<a href=""/q?s=pfe"" name=""pfe"">PFE</a>) confirm that SPK-9001 the lead investigational candidate in the companies' SPK-FIX program has been granted support through the EMA PRIority MEdicines (<a href=""/",2017-03-01 21:16:00 +0000,http://finance.yahoo.com/news/inplay-briefing-com-055139997.html#once,"4:16 pm Spark Therapeutics and Pfizer (<a href=""/q?s=pfe"" name=""pfe"">PFE</a>) confirm that SPK-9001 the lead investigational candidate in the companies' SPK-FIX program has been granted support through the EMA PRIority MEdicines (<a href=""/"
ONCE,ONCE:UW,BBG007TJWN87,"Spark Therapeutics and Pfizer Announce that SPK-9001, an Investigational Hemophilia B Medicine, has been Granted Access to the PRIority MEdicines (PRIME) Program by the European Medicines Agency",2017-03-01 21:15:00 +0000,http://finance.yahoo.com/news/spark-therapeutics-pfizer-announce-spk-211500657.html,"[GlobeNewswire] - PHILADELPHIA and NEW YORK, March 01, 2017-- Spark Therapeutics and Pfizer Inc. announced today that SPK-9001, the lead investigational candidate in the companies' SPK-FIX program has been granted support ..."
ONCE,ONCE:UW,BBG007TJWN87,"Spark Therapeutics and Pfizer Announce that SPK-9001, an Investigational Hemophilia B Medicine, has been Granted Access to the PRIority MEdicines (PRIME) Program by the European Medicines Agency",2017-03-01 21:15:00 +0000,http://finance.yahoo.com/news/spark-therapeutics-pfizer-announce-spk-211500657.html?.tsrc=rss,"PHILADELPHIA and NEW YORK, March 01, 2017-- Spark Therapeutics and Pfizer Inc. announced today that SPK-9001, the lead investigational candidate in the companies' SPK-FIX program has been granted support ..."
ONCE,ONCE:UW,BBG007TJWN87,"SPARK THERAPEUTICS, INC. Files SEC form 10-K, Annual Report",2017-02-28 23:39:10 +0000,http://biz.yahoo.com/e/170228/once10-k.html,"SPARK THERAPEUTICS, INC. Files SEC form 10-K, Annual Report"
ONCE,ONCE:UW,BBG007TJWN87,[$$] Medical Megadeals Dominate Deal Flow,2017-02-27 14:21:35 +0000,https://www.wsj.com/articles/medical-megadeals-dominate-deal-flow-1488205287?mod=yahoo_hs,[$$] Medical Megadeals Dominate Deal Flow
ONCE,ONCE:UW,BBG007TJWN87,"Spark Therapeutics, Inc. :ONCE-US: Earnings Analysis: 2016 By the Numbers : February 24, 2017",2017-02-24 16:26:47 +0000,http://www.capitalcube.com/blog/index.php/spark-therapeutics-inc-once-us-earnings-analysis-2016-by-the-numbers-february-24-2017/,"Spark Therapeutics, Inc. :ONCE-US: Earnings Analysis: 2016 By the Numbers : February 24, 2017"
ONCE,ONCE:UW,BBG007TJWN87,"Spark Therapeutics, Inc. :ONCE-US: Earnings Analysis: 2016 By the Numbers : February 24, 2017",2017-02-24 16:26:47 +0000,http://finance.yahoo.com/r/055f1d7e-1e96-3ce2-8b77-0d331e8d4ae6/spark-therapeutics-inc-once-us-earnings-analysis-2016-by-the-numbers-february-24-2017?yptr=yahoo&.tsrc=rss,"Categories:   Yahoo Finance Get free summary analysis Spark Therapeutics, Inc. reports financial results for the year ended December 31, 2016. We analyze the earnings along side the following peers of Spark Therapeutics, Inc. – Immunomedics, Inc. and Illumina, Inc. (IMMU-US and ILMN-US) that have also reported for this period. Highlights Narrowing of operating margins contributed to decline in ... Read more    
<b>(Read more...)</b>"
ONCE,ONCE:UW,BBG007TJWN87,Edited Transcript of ONCE earnings conference call or presentation 22-Feb-17 1:30pm GMT,2017-02-22 19:31:22 +0000,http://finance.yahoo.com/news/edited-transcript-once-earnings-conference-193122002.html?.tsrc=rss,Q4 2016 Spark Therapeutics Inc Earnings Call
ONCE,ONCE:UW,BBG007TJWN87,Edited Transcript of ONCE earnings conference call or presentation 22-Feb-17 1:30pm GMT,2017-02-22 19:31:22 +0000,http://finance.yahoo.com/news/edited-transcript-once-earnings-conference-193122002.html,Edited Transcript of ONCE earnings conference call or presentation 22-Feb-17 1:30pm GMT
ONCE,ONCE:UW,BBG007TJWN87,Why Spark's CEO says 2017 may be a 'historic year' for his gene therapy company,2017-02-22 17:25:09 +0000,http://www.bizjournals.com/philadelphia/news/2017/02/22/spark-therapeutics-gene-therapy-final-stages-once.html?ana=yahoo,Why Spark's CEO says 2017 may be a 'historic year' for his gene therapy company
ONCE,ONCE:UW,BBG007TJWN87,Why Spark's CEO says 2017 may be a 'historic year' for his gene therapy company,2017-02-22 17:25:09 +0000,http://finance.yahoo.com/r/b8f93dbc-2c81-35dd-a85c-04eb57ef35ff/spark-therapeutics-gene-therapy-final-stages-once.html?ana=yahoo&yptr=yahoo&.tsrc=rss,"Philadelphia gene therapy company Spark Therapeutics said it is in the final stages of completing its rolling biologics license application for its lead product: a one-time treatment for an inherited retinal disease that causes blindness in children.  The application for voretigene neparvovec— which is being submitted in parts to the Food and Drug Administration— is expected be done in early 2017, pending the finalization of the remaining release and stability testing, the company said.  “We look forward to continued innovation, execution and growth in 2017, which may be a historic year for Spark Therapeutics and for patients as we potentially deliver what has been unimaginable before – the first gene therapy in the United States for a genetic disease,” said Jeffrey D. Marrazzo, the company’s co-founder and CEO."
ONCE,ONCE:UW,BBG007TJWN87,Spark Therapeutics Inc Earnings Call scheduled for 8:30 am ET today,2017-02-22 13:30:00 +0000,http://biz.yahoo.com/cc/6/155886.html,Spark Therapeutics Inc Earnings Call scheduled for 8:30 am ET today
ONCE,ONCE:UW,BBG007TJWN87,"SPARK THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and",2017-02-22 12:50:53 +0000,http://biz.yahoo.com/e/170222/once8-k.html,"SPARK THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and"
ONCE,ONCE:UW,BBG007TJWN87,Spark Therapeutics Reports 2016 Financial Results and Business Highlights,2017-02-22 12:30:00 +0000,http://finance.yahoo.com/news/spark-therapeutics-reports-2016-financial-123000312.html?.tsrc=rss,"Investigational voretigene neparvovec Biologics License Application on track for completion in early 2017. Three additional clinical-stage programs continue to advance, including initiation of hemophilia ..."
ONCE,ONCE:UW,BBG007TJWN87,Spark Therapeutics Reports 2016 Financial Results and Business Highlights,2017-02-22 12:30:00 +0000,http://finance.yahoo.com/news/spark-therapeutics-reports-2016-financial-123000312.html,"[GlobeNewswire] - Investigational voretigene neparvovec Biologics License Application on track for completion in early 2017. Three additional clinical-stage programs continue to advance, including initiation of hemophilia ..."
ONCE,ONCE:UW,BBG007TJWN87,"Spark Therapeutics to Host Conference Call on Wednesday, Feb. 22 at 8:30 a.m. to Discuss 2016 Results",2017-02-15 12:30:00 +0000,http://finance.yahoo.com/news/spark-therapeutics-host-conference-call-123000621.html?.tsrc=rss,"PHILADELPHIA, Feb. 15, 2017-- Spark Therapeutics, a fully integrated gene therapy company dedicated to challenging the inevitability of genetic disease, will host a conference call on Wednesday, Feb. 22, ..."
ONCE,ONCE:UW,BBG007TJWN87,"Spark Therapeutics to Host Conference Call on Wednesday, Feb. 22 at 8:30 a.m. to Discuss 2016 Results",2017-02-15 12:30:00 +0000,http://finance.yahoo.com/news/spark-therapeutics-host-conference-call-123000621.html,"[GlobeNewswire] - PHILADELPHIA, Feb. 15, 2017-- Spark Therapeutics, a fully integrated gene therapy company dedicated to challenging the inevitability of genetic disease, will host a conference call on Wednesday, Feb. 22, ..."
ONCE,ONCE:UW,BBG007TJWN87,Abeona: Preparing For Liftoff - The Next Avexis?,2017-02-14 15:18:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-b2MqGaF2SE/abeona-preparing-for-liftoff-the-next-avexis-cm747604,By World s Greatest ByWorld s Greatest Executive Summary and Investment Thesis Executive Summary and Investment ThesisExecutive Summary and Investment Thesis Abeona Therapeutics ABEO is a biotechnology company with a number of early and late stage assets This week the company
ONCE,ONCE:UW,BBG007TJWN87,"Commit To Buy Spark Therapeutics At $55, Earn 18.5% Annualized Using Options",2017-02-08 18:17:12 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UgFc8FWHFBY/commit-to-buy-spark-therapeutics-at-55-earn-185-annualized-using-options-cm744986,Investors eyeing a purchase of Spark Therapeutics Inc Symbol ONCE shares but cautious about paying the going market price of 62 58 share might benefit from considering selling puts among the alternative strategies at their disposal One interesting put contract in particular is the
ONCE,ONCE:UW,BBG007TJWN87,Spark Therapeutics to Participate in Multiple February Conferences,2017-01-26 12:36:44 +0000,http://finance.yahoo.com/news/spark-therapeutics-participate-multiple-february-123644374.html,"[GlobeNewswire] - PHILADELPHIA, Jan. 26, 2017-- Spark Therapeutics, a fully integrated gene therapy company dedicated to challenging the inevitability of genetic disease, announced today that members of company management ..."
ONCE,ONCE:UW,BBG007TJWN87,Spark Therapeutics to Participate in Multiple February Conferences,2017-01-26 12:36:44 +0000,http://finance.yahoo.com/news/spark-therapeutics-participate-multiple-february-123644374.html?.tsrc=rss,"PHILADELPHIA, Jan. 26, 2017-- Spark Therapeutics, a fully integrated gene therapy company dedicated to challenging the inevitability of genetic disease, announced today that members of company management ..."
ONCE,ONCE:UW,BBG007TJWN87,"Spark Therapeutics, Inc. breached its 50 day moving average in a Bearish Manner : ONCE-US : January 18, 2017",2017-01-18 14:49:42 +0000,http://www.capitalcube.com/blog/index.php/spark-therapeutics-inc-breached-its-50-day-moving-average-in-a-bearish-manner-once-us-january-18-2017/,"Spark Therapeutics, Inc. breached its 50 day moving average in a Bearish Manner : ONCE-US : January 18, 2017"
ONCE,ONCE:UW,BBG007TJWN87,"Spark Therapeutics, Inc. breached its 50 day moving average in a Bearish Manner : ONCE-US : January 18, 2017",2017-01-18 14:49:42 +0000,http://finance.yahoo.com/r/36ea3569-e4a3-3b75-b9b8-df86b410e63b/spark-therapeutics-inc-breached-its-50-day-moving-average-in-a-bearish-manner-once-us-january-18-2017?yptr=yahoo&.tsrc=rss,"Categories:   ETFs Yahoo Finance Click here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Spark Therapeutics, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving ... Read more    
<b>(Read more...)</b>"
ONCE,ONCE:UW,BBG007TJWN87,Spark Therapeutics Announces U.S. Orphan Drug Designation Amendment and Study Updates for Lead Investigational Gene Therapy,2017-01-09 12:30:00 +0000,http://finance.yahoo.com/news/spark-therapeutics-announces-u-orphan-123000538.html,"[GlobeNewswire] - FDA grants request to amend orphan drug designation for voretigene neparvovec to encompass all Inherited Retinal Disease caused by biallelic RPE65 mutations, which is aligned with proposed indication. ..."
ONCE,ONCE:UW,BBG007TJWN87,Spark Gets A Check From Pfizer And A Downgrade From Vetr,2017-01-05 21:39:33 +0000,http://finance.yahoo.com/news/spark-gets-check-pfizer-downgrade-213933976.html,Spark Gets A Check From Pfizer And A Downgrade From Vetr
ONCE,ONCE:UW,BBG007TJWN87,Spark Gets A Check From Pfizer And A Downgrade From Vetr,2017-01-05 21:39:33 +0000,http://finance.yahoo.com/news/spark-gets-check-pfizer-downgrade-213933976.html?.tsrc=rss,"The Vetr crowd downgraded their rating for Spark Therapeutics Inc (NASDAQ: ONCE ) on Thursday, from 4.5 stars (Strong Buy), issued 519 days ago, to 4 stars (Buy). Crowd sentiment for Spark is primarily ..."
ONCE,ONCE:UW,BBG007TJWN87,Spark Therapeutics Gets $15M Milestone Payment from Pfizer,2017-01-05 17:39:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hKwpmkvrZBk/spark-therapeutics-gets-15m-milestone-payment-from-pfizer-cm729886,Spark Therapeutics ONCE received a 15 million milestone payment from partner Pfizer Inc PFE for achieving a pre specified safety and efficacy profile in the phase I II study on SPK 9001 which is being evaluated for the treatment of hemophilia B Spark Therapeutics share price has gained
ONCE,ONCE:UW,BBG007TJWN87,"Company News for January 05, 2017",2017-01-05 17:39:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dlHf-htaWiQ/company-news-for-january-05-2017-cm729883,Spark Therapeutics Inc s ONCE shares jumped 10 8 on news that Pfizer Inc PFE paid 15 million to the company following its success in developing treatment to cure hemophilia B Shares of Carnival Corporation CCL increased 1 3 following news that the company has decided
ONCE,ONCE:UW,BBG007TJWN87,"Spark Therapeutics, Inc. – Value Analysis (NASDAQ:ONCE) : January 5, 2017",2017-01-05 16:30:54 +0000,http://www.capitalcube.com/blog/index.php/spark-therapeutics-inc-value-analysis-nasdaqonce-january-5-2017/,"Spark Therapeutics, Inc. – Value Analysis (NASDAQ:ONCE) : January 5, 2017"
ONCE,ONCE:UW,BBG007TJWN87,"Spark Therapeutics, Inc. – Value Analysis (NASDAQ:ONCE) : January 5, 2017",2017-01-05 16:30:54 +0000,http://finance.yahoo.com/r/d56d5ccf-95de-377e-93f1-d0b4049a5fa2/spark-therapeutics-inc-value-analysis-nasdaqonce-january-5-2017?yptr=yahoo&.tsrc=rss,"Categories:   Fundamental Analysis Yahoo Finance Click here to see latest analysis Capitalcube gives Spark Therapeutics, Inc. a score of 20. Our analysis is based on comparing Spark Therapeutics, Inc. with the following peers – Immunomedics, Inc., Harvard Bioscience, Inc., FibroGen, Inc. and Illumina, Inc. (IMMU-US, HBIO-US, FGEN-US and ILMN-US). Investment Outlook Spark Therapeutics, Inc. has a fundamental score of 20 ... Read more    
<b>(Read more...)</b>"
ONCE,ONCE:UW,BBG007TJWN87,"Company News for January 05, 2017",2017-01-05 15:10:03 +0000,http://finance.yahoo.com/news/company-news-january-05-2017-151003764.html,"Company News for January 05, 2017"
ONCE,ONCE:UW,BBG007TJWN87,Spark Therapeutics Gets $15M Milestone Payment from Pfizer,2017-01-05 15:09:03 +0000,http://finance.yahoo.com/news/spark-therapeutics-gets-15m-milestone-150903751.html,Spark Therapeutics Gets $15M Milestone Payment from Pfizer
ONCE,ONCE:UW,BBG007TJWN87,Spark reels in second $15M payment from Pfizer,2017-01-04 18:40:14 +0000,http://www.bizjournals.com/philadelphia/news/2017/01/04/spark-therapeutics-pfier-payment-once-gene-spk.html?ana=yahoo,Spark reels in second $15M payment from Pfizer
ONCE,ONCE:UW,BBG007TJWN87,"Spark Therapeutics, Inc. breached its 50 day moving average in a Bullish Manner : ONCE-US : January 4, 2017",2017-01-04 13:06:32 +0000,http://www.capitalcube.com/blog/index.php/spark-therapeutics-inc-breached-its-50-day-moving-average-in-a-bullish-manner-once-us-january-4-2017/,"Spark Therapeutics, Inc. breached its 50 day moving average in a Bullish Manner : ONCE-US : January 4, 2017"
ONCE,ONCE:UW,BBG007TJWN87,Spark Therapeutics Jumps On Milestone Payment From Pfizer,2017-01-04 12:46:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/LmIHTqs_Od0/spark-therapeutics-jumps-on-milestone-payment-from-pfizer-20170104-00860,Spark Therapeutics Jumps On Milestone Payment From Pfizer
ONCE,ONCE:UW,BBG007TJWN87,Spark Therapeutics Announces $15 Million Milestone Payment from Pfizer for Progress in Hemophilia B Gene Therapy Program,2017-01-04 12:30:00 +0000,http://finance.yahoo.com/news/spark-therapeutics-announces-15-million-123000647.html,"[GlobeNewswire] - PHILADELPHIA, Jan. 04, 2017-- Spark Therapeutics, a fully integrated gene therapy company dedicated to challenging the inevitability of genetic disease, today announced that it has earned a $15 million ..."
ONCE,ONCE:UW,BBG007TJWN87,Spark Therapeutics Announces Milestone Payment From Pfizer - Quick Facts,2017-01-04 07:36:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2JKX7gWFces/spark-therapeutics-announces-milestone-payment-from-pfizer--quick-facts-20170104-00260,Spark Therapeutics Announces Milestone Payment From Pfizer - Quick Facts
ONCE,ONCE:UW,BBG007TJWN87,Spark Therapeutics to Participate in J.P. Morgan Healthcare Conference,2017-01-03 21:05:00 +0000,http://finance.yahoo.com/news/spark-therapeutics-participate-j-p-210500907.html,"[GlobeNewswire] - PHILADELPHIA, Jan. 03, 2017-- Spark Therapeutics, a fully integrated gene therapy company dedicated to challenging the inevitability of genetic disease, announced today that Jeffrey D. Marrazzo, chief ..."
ONCE,ONCE:UW,BBG007TJWN87,"Friday Sector Leaders: Drugs, Biotechnology Stocks",2016-12-23 19:58:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XmL1eoT94Po/friday-sector-leaders-drugs-biotechnology-stocks-cm725833,In trading on Friday drugs shares were relative leaders up on the day by about 2 1 Leading the group were shares of Conatus Pharmaceuticals CNAT up about 14 8 and shares of Cardiome Pharma CRME up about 11 8 on the day Also showing relative strength are biotechnology
ONCE,ONCE:UW,BBG007TJWN87,"Friday's ETF Movers: XBI, OIH",2016-12-23 19:57:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OADjcKvsuJw/fridays-etf-movers-xbi-oih-cm725831,In trading on Friday the SPDR S amp P Biotech ETF XBI is outperforming other ETFs up about 2 3 on the day Components of that ETF showing particular strength include shares of Synergy Pharmaceuticals SGYP up about 10 6 and shares of Spark Therapeutics ONCE up about 8 on
ONCE,ONCE:UW,BBG007TJWN87,Spark Therapeutics Breaks Below 200-Day Moving Average - Notable for ONCE,2016-12-21 17:58:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/v9PLIpmXC08/spark-therapeutics-breaks-below-200-day-moving-average-notable-for-once-cm724664,In trading on Wednesday shares of Spark Therapeutics Inc Symbol ONCE crossed below their 200 day moving average of 49 88 changing hands as low as 49 45 per share Spark Therapeutics Inc shares are currently trading down about 5 1 on the day The chart below shows the one year performance
ONCE,ONCE:UW,BBG007TJWN87,"Massive Bill Ackman Trade Highlights Insider Selling: Valeant Pharmaceuticals, Starbucks, Schlumberger, Validus and More",2016-12-17 14:45:08 +0000,http://247wallst.com/investing/2016/12/17/massive-bill-ackman-trade-highlights-insider-selling-valeant-pharmaceuticals-starbucks-schlumberger-validus-and-more/,"Massive Bill Ackman Trade Highlights Insider Selling: Valeant Pharmaceuticals, Starbucks, Schlumberger, Validus and More"
ONCE,ONCE:UW,BBG007TJWN87,Is MRC Global Inc (MRC) A Good Stock To Buy?,2016-12-13 15:57:31 +0000,http://www.insidermonkey.com/blog/is-mrc-global-inc-mrc-a-good-stock-to-buy-2-496222/,Is MRC Global Inc (MRC) A Good Stock To Buy?
ONCE,ONCE:UW,BBG007TJWN87,"SPARK THERAPEUTICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement",2016-12-08 14:30:36 +0000,http://biz.yahoo.com/e/161208/once8-k.html,"SPARK THERAPEUTICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement"
ONCE,ONCE:UW,BBG007TJWN87,"Spark Therapeutics, Inc. breached its 50 day moving average in a Bearish Manner : ONCE-US : December 8, 2016",2016-12-08 12:47:50 +0000,http://www.capitalcube.com/blog/index.php/spark-therapeutics-inc-breached-its-50-day-moving-average-in-a-bearish-manner-once-us-december-8-2016/,"Spark Therapeutics, Inc. breached its 50 day moving average in a Bearish Manner : ONCE-US : December 8, 2016"
ONCE,ONCE:UW,BBG007TJWN87,Hedge Funds Aren’t Crazy About Spark Therapeutics Inc (ONCE) Anymore,2016-12-07 16:25:08 +0000,http://www.insidermonkey.com/blog/hedge-funds-arent-crazy-about-spark-therapeutics-inc-once-anymore-500697/,Hedge Funds Aren’t Crazy About Spark Therapeutics Inc (ONCE) Anymore
ONCE,ONCE:UW,BBG007TJWN87,"Rivals Kite Pharma, Juno Therapeutics Tank On Cancer Data; Spark Flies",2016-12-06 21:31:24 +0000,http://www.investors.com/news/technology/rivals-kite-pharma-juno-therapeutics-tank-on-cancer-data-spark-flies/,"Rivals Kite Pharma, Juno Therapeutics Tank On Cancer Data; Spark Flies"
ONCE,ONCE:UW,BBG007TJWN87,"SPARK THERAPEUTICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers",2016-12-05 21:32:46 +0000,http://biz.yahoo.com/e/161205/once8-k.html,"SPARK THERAPEUTICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers"
ONCE,ONCE:UW,BBG007TJWN87,Blood Work: A Few Biotech Thoughts From Sunny San Diego and the ASH 2016 Meeting,2016-12-05 18:11:00 +0000,https://www.thestreet.com/story/13914499/1/blood-work-a-few-biotech-thoughts-from-sunny-san-diego-and-the-ash-2016-meeting.html?puc=yahoo&cm_ven=YAHOO,Blood Work: A Few Biotech Thoughts From Sunny San Diego and the ASH 2016 Meeting
ONCE,ONCE:UW,BBG007TJWN87,Here’s Why We Think There’s Opportunity In Uniqure NV (QURE),2016-12-05 16:33:31 +0000,http://www.insidermonkey.com/blog/heres-why-we-think-theres-opportunity-in-uniqure-nv-qure-498835/,Here’s Why We Think There’s Opportunity In Uniqure NV (QURE)
ONCE,ONCE:UW,BBG007TJWN87,Spark lights up licensing deal valued at up to $460M,2016-12-05 16:10:09 +0000,http://www.bizjournals.com/philadelphia/news/2016/12/05/spark-therapeutics-selecta-biosciences-virus-biote.html?ana=yahoo,Spark lights up licensing deal valued at up to $460M
ONCE,ONCE:UW,BBG007TJWN87,Spark Therapeutics Adds Chief Operating Officer to Management Team,2016-12-05 12:01:00 +0000,http://finance.yahoo.com/news/spark-therapeutics-adds-chief-operating-120100800.html,"[GlobeNewswire] - PHILADELPHIA, Dec. 05, 2016-- Spark Therapeutics, a fully integrated gene therapy company dedicated to challenging the inevitability of genetic disease, today announced the appointment of John Furey to ..."
ONCE,ONCE:UW,BBG007TJWN87,Spark Therapeutics Enters into Licensing Agreement with Selecta Biosciences,2016-12-05 12:00:00 +0000,http://finance.yahoo.com/news/spark-therapeutics-enters-licensing-agreement-120000475.html,"[GlobeNewswire] - Exclusive use of Selecta’ s Synthetic Vaccine Particles platform technology provided to Spark Therapeutics for co-administration with up to five gene therapy targets, including FVIII for hemophilia A. ..."
ONCE,ONCE:UW,BBG007TJWN87,Spark's Hemophilia Gene Therapy Remains Effective Despite Immune Reactions,2016-12-03 18:04:00 +0000,https://www.thestreet.com/story/13913098/1/spark-s-hemophilia-gene-therapy-remains-effective-despite-immune-reactions.html?puc=yahoo&cm_ven=YAHOO,Spark's Hemophilia Gene Therapy Remains Effective Despite Immune Reactions
ONCE,ONCE:UW,BBG007TJWN87,Spark Therapeutics and Pfizer Present Updated Preliminary Data from Hemophilia B Phase 1/2 Trial Suggesting Consistent and Sustained Levels of Factor IX Activity at Annual ASH Meeting,2016-12-03 16:00:00 +0000,http://finance.yahoo.com/news/spark-therapeutics-pfizer-present-updated-160000142.html,"[GlobeNewswire] - Together, all nine participants have reduced infusions of factor IX concentrates by 99 percent over cumulative 1,650 days. Seven infused participants who have progressed to at least 12 weeks post-vector ..."
ONCE,ONCE:UW,BBG007TJWN87,"Celgene, Kite, Spark Look To Sidestep Lilly Alzheimer's Flop",2016-11-30 21:15:50 +0000,http://www.investors.com/news/technology/celgene-kite-spark-look-to-sidestep-lilly-alzheimers-flop-at-ash/,"Celgene, Kite, Spark Look To Sidestep Lilly Alzheimer's Flop"
ONCE,ONCE:UW,BBG007TJWN87,Spark Therapeutics Announces Multiple Presentations on Updated Hemophilia B Phase 1/2 Data at American Society of Hematology Annual Meeting,2016-11-30 12:30:00 +0000,http://finance.yahoo.com/news/spark-therapeutics-announces-multiple-presentations-123000752.html,"[GlobeNewswire] - PHILADELPHIA, Nov. 30, 2016-- Spark Therapeutics, a fully integrated gene therapy company dedicated to challenging the inevitability of genetic disease, announced today that Katherine High, M.D., president ..."
ONCE,ONCE:UW,BBG007TJWN87,"ETFs with exposure to Spark Therapeutics, Inc. : November 29, 2016",2016-11-29 19:17:29 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-spark-therapeutics-inc-november-29-2016/,"ETFs with exposure to Spark Therapeutics, Inc. : November 29, 2016"
ONCE,ONCE:UW,BBG007TJWN87,Edited Transcript of ONCE earnings conference call or presentation 3-Nov-16 12:30pm GMT,2016-11-28 21:03:48 +0000,http://finance.yahoo.com/news/edited-transcript-once-earnings-conference-210348875.html,Edited Transcript of ONCE earnings conference call or presentation 3-Nov-16 12:30pm GMT
ONCE,ONCE:UW,BBG007TJWN87,"Spark Therapeutics, Inc. breached its 50 day moving average in a Bullish Manner : ONCE-US : November 28, 2016",2016-11-28 12:18:55 +0000,http://www.capitalcube.com/blog/index.php/spark-therapeutics-inc-breached-its-50-day-moving-average-in-a-bullish-manner-once-us-november-28-2016/,"Spark Therapeutics, Inc. breached its 50 day moving average in a Bullish Manner : ONCE-US : November 28, 2016"
ONCE,ONCE:UW,BBG007TJWN87,"ETFs with exposure to Spark Therapeutics, Inc. : November 15, 2016",2016-11-15 19:07:55 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-spark-therapeutics-inc-november-15-2016/,"ETFs with exposure to Spark Therapeutics, Inc. : November 15, 2016"
ONCE,ONCE:UW,BBG007TJWN87,"Spark Therapeutics, Inc. :ONCE-US: Earnings Analysis: Q3, 2016 By the Numbers : November 14, 2016",2016-11-14 16:09:45 +0000,http://www.capitalcube.com/blog/index.php/spark-therapeutics-inc-once-us-earnings-analysis-q3-2016-by-the-numbers-november-14-2016/,"Spark Therapeutics, Inc. :ONCE-US: Earnings Analysis: Q3, 2016 By the Numbers : November 14, 2016"
ONCE,ONCE:UW,BBG007TJWN87,"Spark Therapeutics, Inc. breached its 50 day moving average in a Bullish Manner : ONCE-US : November 14, 2016",2016-11-14 13:01:29 +0000,http://www.capitalcube.com/blog/index.php/spark-therapeutics-inc-breached-its-50-day-moving-average-in-a-bullish-manner-once-us-november-14-2016/,"Spark Therapeutics, Inc. breached its 50 day moving average in a Bullish Manner : ONCE-US : November 14, 2016"
ONCE,ONCE:UW,BBG007TJWN87,Spark Therapeutics Inc (ONCE) and Other Profitable Healthcare Picks of Casdin Capital,2016-11-05 22:33:30 +0000,http://www.insidermonkey.com/blog/spark-therapeutics-inc-once-and-other-profitable-healthcare-picks-of-casdin-capital-485077/,Spark Therapeutics Inc (ONCE) and Other Profitable Healthcare Picks of Casdin Capital
ONCE,ONCE:UW,BBG007TJWN87,Spark Therapeutics 3Q Loss $1.07 a Share (ONCE),2016-11-05 14:24:00 +0000,http://www.investopedia.com/news/spark-therapeutics-3q-loss-missed-street-once/?partner=YahooSA,Spark Therapeutics 3Q Loss $1.07 a Share (ONCE)
ONCE,ONCE:UW,BBG007TJWN87,"SPARK THERAPEUTICS, INC. Files SEC form 10-Q, Quarterly Report",2016-11-04 20:33:21 +0000,http://biz.yahoo.com/e/161104/once10-q.html,"SPARK THERAPEUTICS, INC. Files SEC form 10-Q, Quarterly Report"
ONCE,ONCE:UW,BBG007TJWN87,"ACHN Tanks, INNL''s Acts Fail, LCI In The Crosshair Of Law, ONCE Loses Its Spark",2016-11-04 03:44:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/WBMAZAXetGU/achn-tanks-innls-acts-fail-lci-in-the-crosshair-of-law-once-loses-its-spark-20161104-00065,"ACHN Tanks, INNL''s Acts Fail, LCI In The Crosshair Of Law, ONCE Loses Its Spark"
ONCE,ONCE:UW,BBG007TJWN87,Spark Therapeutics Inc. Tumbled as Much as 25% on Thursday -- Here's Why,2016-11-03 21:08:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UMEPoe80Y84/spark-therapeutics-inc-tumbled-as-much-as-25-on-thursday-heres-why-cm703620,Image source Getty Images What happened Shares of Spark Therapeutics NASDAQ ONCE a clinical stage gene therapy company plunged as much as 25 during Thursday afternoon s trading session after Spark and its development partner Pfizer NYSE PFE released an abstract
ONCE,ONCE:UW,BBG007TJWN87,Spark Therapeutics Inc. Tumbled as Much as 25% on Thursday -- Here's Why,2016-11-03 19:57:02 +0000,http://www.fool.com/investing/2016/11/03/spark-therapeutics-inc-tumbled-as-much-as-25-on-th.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Spark Therapeutics Inc. Tumbled as Much as 25% on Thursday -- Here's Why
ONCE,ONCE:UW,BBG007TJWN87,Spark Therapeutics (ONCE) Shares Cross Below 200 DMA,2016-11-03 18:07:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/gd2ZutFmwww/spark-therapeutics-once-shares-cross-below-200-dma-cm703442,In trading on Thursday shares of Spark Therapeutics Inc Symbol ONCE crossed below their 200 day moving average of 46 00 changing hands as low as 35 65 per share Spark Therapeutics Inc shares are currently trading down about 17 1 on the day The chart below shows the one year performance
ONCE,ONCE:UW,BBG007TJWN87,The Great 'ASH16' Abstract Drop Mostly Causes Drug Stocks to Do Same,2016-11-03 14:31:00 +0000,https://www.thestreet.com/story/13879629/1/the-great-ash16-abstract-drop-mostly-causes-drug-stocks-to-do-same.html?puc=yahoo&cm_ven=YAHOO,The Great 'ASH16' Abstract Drop Mostly Causes Drug Stocks to Do Same
ONCE,ONCE:UW,BBG007TJWN87,Spark Therapeutics and Pfizer Announce Updated Data from Hemophilia B Phase 1/2 Trial Suggesting Sustained Therapeutic Levels of Factor IX Activity,2016-11-03 13:18:12 +0000,http://www.publicnow.com/view/15262E93454C0C4072ACC809631F06208D61695D,"[at noodls] - First seven participants, through a combined 103 weeks of observation as of Aug. 4, 2016, did not need infusions of factor IX concentrates to prevent bleeding Updated SPK-9001 data in hemophilia B to be ..."
ONCE,ONCE:UW,BBG007TJWN87,Spark Therapeutics reports 3Q loss,2016-11-03 13:04:24 +0000,http://sg.finance.yahoo.com/news/spark-therapeutics-reports-3q-loss-130424275.html,Spark Therapeutics reports 3Q loss
ONCE,ONCE:UW,BBG007TJWN87,Spark Therapeutics Reports Third Quarter 2016 Financial Results and Recent Business Highlights,2016-11-03 12:18:13 +0000,http://www.publicnow.com/view/68B93238FD4087F1A913056194D8042A2349E903,"[at noodls] - Completion of Biologics Licensing Application (BLA) submission for investigational candidate voretigene neparvovec on track for early 2017 Company makes progress across multiple programs, including its ..."
ONCE,ONCE:UW,BBG007TJWN87,"SPARK THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and",2016-11-03 12:06:54 +0000,http://biz.yahoo.com/e/161103/once8-k.html,"SPARK THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and"
ONCE,ONCE:UW,BBG007TJWN87,Q3 2016 Spark Therapeutics Inc Earnings Release - Before Market Open,2016-11-03 11:07:09 +0000,http://biz.yahoo.com/research/earncal/20161103.html?t=once,Q3 2016 Spark Therapeutics Inc Earnings Release - Before Market Open
ONCE,ONCE:UW,BBG007TJWN87,Spark Therapeutics to Participate in Multiple Upcoming Conferences,2016-10-31 11:30:00 +0000,http://finance.yahoo.com/news/spark-therapeutics-participate-multiple-upcoming-113000993.html,"[GlobeNewswire] - PHILADELPHIA, Oct. 31, 2016-- Spark Therapeutics, a fully integrated gene therapy company seeking to transform the lives of patients with debilitating genetic diseases by developing investigational, potentially ..."
ONCE,ONCE:UW,BBG007TJWN87,Relative Strength Alert For Spark Therapeutics,2016-10-27 21:43:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6yCC3j4bjDw/relative-strength-alert-for-spark-therapeutics-cm699828,Legendary investor Warren Buffett advises to be fearful when others are greedy and be greedy when others are fearful One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index or RSI which measures momentum on
ONCE,ONCE:UW,BBG007TJWN87,"Spark Therapeutics to Host Conference Call on Thursday, Nov. 3 at 8:30 a.m. to Discuss Third Quarter 2016 Results",2016-10-27 11:46:20 +0000,http://www.publicnow.com/view/A3BB22C08BE253D95165F486511BF709474D6643,"[at noodls] - PHILADELPHIA, Oct. 27, 2016 (GLOBE NEWSWIRE) -- Spark Therapeutics (NASDAQ:ONCE), a fully integrated gene therapy company seeking to transform the lives of patients with debilitating genetic diseases by ..."
ONCE,ONCE:UW,BBG007TJWN87,Spark Therapeutics Announces Collaboration with Leading Gene Therapy Center at University of Massachusetts Medical School,2016-10-20 08:38:01 +0000,http://www.publicnow.com/view/05157CA99C209302083223D5637DD830508001FA,"[at noodls] - PHILADELPHIA, Oct. 20, 2016 (GLOBE NEWSWIRE) -- Spark Therapeutics (NASDAQ:ONCE), a fully integrated gene therapy company seeking to transform the lives of patients with debilitating genetic diseases by ..."
ONCE,ONCE:UW,BBG007TJWN87,Data Presented Today at the American Academy of Ophthalmology 2016 Annual Meeting Reinforce Efficacy and Durability of Voretigene Neparvovec in RPE65-Mediated Inherited Retinal Disease,2016-10-14 17:15:00 +0000,http://finance.yahoo.com/news/data-presented-today-american-academy-171500804.html,"[GlobeNewswire] - PHILADELPHIA, Oct. 14, 2016-- Spark Therapeutics, a fully integrated gene therapy company seeking to transform the lives of patients with debilitating genetic diseases by developing investigational, potentially ..."
ONCE,ONCE:UW,BBG007TJWN87,Spark launches genetic testing initiative for inherited eye disease,2016-10-13 15:10:12 +0000,http://www.bizjournals.com/philadelphia/news/2016/10/13/spark-inherited-eye-disease-id-your-ird-genetic.html?ana=yahoo,Spark launches genetic testing initiative for inherited eye disease
ONCE,ONCE:UW,BBG007TJWN87,"Spark Therapeutics, Inc. breached its 50 day moving average in a Bearish Manner : ONCE-US : October 13, 2016",2016-10-13 12:26:52 +0000,http://www.capitalcube.com/blog/index.php/spark-therapeutics-inc-breached-its-50-day-moving-average-in-a-bearish-manner-once-us-october-13-2016/,"Spark Therapeutics, Inc. breached its 50 day moving average in a Bearish Manner : ONCE-US : October 13, 2016"
ONCE,ONCE:UW,BBG007TJWN87,Spark Therapeutics Launches Initiative to Improve Access to Genetic Testing for Inherited Retinal Diseases,2016-10-13 11:50:01 +0000,http://www.publicnow.com/view/15FE6BB42F2EB947B6CEF5FF6215D8BF1072A265,"[at noodls] - PHILADELPHIA, Oct. 13, 2016 (GLOBE NEWSWIRE) -- Spark Therapeutics (NASDAQ:ONCE) will provide physicians and eligible patients access to genetic testing and counseling for more than 30 genes linked to ..."
ONCE,ONCE:UW,BBG007TJWN87,Spark Therapeutics to Participate in AAO Annual Meeting,2016-10-10 11:30:00 +0000,http://finance.yahoo.com/news/spark-therapeutics-participate-aao-annual-113000405.html,"[GlobeNewswire] - PHILADELPHIA, Oct. 10, 2016-- Spark Therapeutics, a fully integrated gene therapy company seeking to transform the lives of patients with debilitating genetic diseases by developing potential one-time, ..."
ONCE,ONCE:UW,BBG007TJWN87,"BioMarin, Incyte, Kite Get Thumbs Up On Goldman Sachs Upgrade",2016-10-07 20:21:23 +0000,http://www.investors.com/news/technology/biomarin-incyte-kite-get-thumbs-up-on-goldman-sachs-upgrade/,"BioMarin, Incyte, Kite Get Thumbs Up On Goldman Sachs Upgrade"
ONCE,ONCE:UW,BBG007TJWN87,"Spark Therapeutics, Inc. – Value Analysis (NASDAQ:ONCE) : October 3, 2016",2016-10-03 16:25:46 +0000,http://www.capitalcube.com/blog/index.php/spark-therapeutics-inc-value-analysis-nasdaqonce-october-3-2016/,"Spark Therapeutics, Inc. – Value Analysis (NASDAQ:ONCE) : October 3, 2016"
ONCE,ONCE:UW,BBG007TJWN87,"Spark Therapeutics, Inc. breached its 50 day moving average in a Bearish Manner : ONCE-US : September 30, 2016",2016-09-30 12:28:02 +0000,http://www.capitalcube.com/blog/index.php/spark-therapeutics-inc-breached-its-50-day-moving-average-in-a-bearish-manner-once-us-september-30-2016/,"Spark Therapeutics, Inc. breached its 50 day moving average in a Bearish Manner : ONCE-US : September 30, 2016"
ONCE,ONCE:UW,BBG007TJWN87,"ETF’s with exposure to Spark Therapeutics, Inc. : September 29, 2016",2016-09-29 13:46:19 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-spark-therapeutics-inc-september-29-2016/,"ETF’s with exposure to Spark Therapeutics, Inc. : September 29, 2016"
ONCE,ONCE:UW,BBG007TJWN87,This is no time for speculators to stay on the sidelines,2016-09-21 16:23:39 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=E773FFA5-F032-49F1-8967-95F29E94F579&siteid=yhoof2,This is no time for speculators to stay on the sidelines
ONCE,ONCE:UW,BBG007TJWN87,Spark Therapeutics to Participate in Multiple Upcoming Conferences,2016-09-21 11:30:00 +0000,http://finance.yahoo.com/news/spark-therapeutics-participate-multiple-upcoming-113000954.html,"[GlobeNewswire] - PHILADELPHIA, Sept. 21, 2016-- Spark Therapeutics, a fully integrated gene therapy company seeking to transform the lives of patients with debilitating genetic diseases by developing potential one-time, ..."
ONCE,ONCE:UW,BBG007TJWN87,Spark Therapeutics Reaches Analyst Target Price,2016-09-16 17:17:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zYM_cjYRrKA/spark-therapeutics-reaches-analyst-target-price-cm680648,In recent trading shares of Spark Therapeutics Inc Symbol ONCE have crossed above the average analyst 12 month target price of 62 44 changing hands for 63 81 share When a stock reaches the target an analyst has set the analyst logically has two ways to react downgrade on valuation
ONCE,ONCE:UW,BBG007TJWN87,"Jim Cramer's Top Takeaways: Spark Therapeutics, General Mills, Kellogg, ConAgra, Campbell",2016-09-09 10:00:00 +0000,https://www.thestreet.com/story/13622823/1/jim-cramer-s-top-takeaways-spark-therapeutics-general-mills-kellogg-conagra-campbell.html?puc=yahoo&cm_ven=YAHOO,"Jim Cramer's Top Takeaways: Spark Therapeutics, General Mills, Kellogg, ConAgra, Campbell"
ONCE,ONCE:UW,BBG007TJWN87,Cramer Remix: The black hole that investors are just waking up to,2016-09-08 23:20:26 +0000,http://www.cnbc.com/id/103926605?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=103926605,Cramer Remix: The black hole that investors are just waking up to
ONCE,ONCE:UW,BBG007TJWN87,"Allergan Buys Into Gene Therapy, Promises To Limit Price Increases",2016-09-06 20:53:38 +0000,http://www.investors.com/news/technology/allergan-buys-into-gene-therapy-promises-to-limit-price-increases/,"Allergan Buys Into Gene Therapy, Promises To Limit Price Increases"
ONCE,ONCE:UW,BBG007TJWN87,[$$] Health-Care Returns Outpace Tech as Advances Reshape Industry,2016-09-06 12:58:18 +0000,http://www.wsj.com/articles/health-care-returns-outpace-tech-as-advances-reshape-industry-1473166694?mod=yahoo_hs,[$$] Health-Care Returns Outpace Tech as Advances Reshape Industry
ONCE,ONCE:UW,BBG007TJWN87,"Analysts Stay Bullish on Broadcom, Smith & Wesson, Split On Ciena",2016-09-02 20:14:29 +0000,http://www.investors.com/news/analysts-stay-bullish-on-broadcom-smith-wesson-split-on-ciena/,"Analysts Stay Bullish on Broadcom, Smith & Wesson, Split On Ciena"
ONCE,ONCE:UW,BBG007TJWN87,"Top Analyst Upgrades and Downgrades: Carnival, Ciena, MercadoLibre, Spark Therapeutics, Smith & Wesson, Teva, Verifone and More",2016-09-02 13:10:43 +0000,http://247wallst.com/investing/2016/09/02/top-analyst-upgrades-and-downgrades-carnival-ciena-mercadolibre-spark-therapeutics-smith-wesson-teva-verifone-and-more/,"Top Analyst Upgrades and Downgrades: Carnival, Ciena, MercadoLibre, Spark Therapeutics, Smith & Wesson, Teva, Verifone and More"
ONCE,ONCE:UW,BBG007TJWN87,Spark Therapeutics to Participate in Multiple September Conferences,2016-08-31 11:30:00 +0000,http://finance.yahoo.com/news/spark-therapeutics-participate-multiple-september-113000883.html,"[GlobeNewswire] - PHILADELPHIA, Aug. 31, 2016-- Spark Therapeutics, a fully integrated gene therapy company seeking to transform the lives of patients with debilitating genetic diseases by developing one-time, life-altering ..."
ONCE,ONCE:UW,BBG007TJWN87,"ETF’s with exposure to Spark Therapeutics, Inc. : August 30, 2016",2016-08-30 15:24:33 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-spark-therapeutics-inc-august-30-2016/,"ETF’s with exposure to Spark Therapeutics, Inc. : August 30, 2016"
ONCE,ONCE:UW,BBG007TJWN87,"Spark Therapeutics, Inc. breached its 50 day moving average in a Bullish Manner : ONCE-US : August 29, 2016",2016-08-29 12:06:14 +0000,http://www.capitalcube.com/blog/index.php/spark-therapeutics-inc-breached-its-50-day-moving-average-in-a-bullish-manner-once-us-august-29-2016/,"Spark Therapeutics, Inc. breached its 50 day moving average in a Bullish Manner : ONCE-US : August 29, 2016"
ONCE,ONCE:UW,BBG007TJWN87,"Lots of Insiders Are Selling Apple, Facebook, Activision Blizzard and More",2016-08-21 14:25:17 +0000,http://247wallst.com/investing/2016/08/21/lots-of-insiders-are-selling-apple-facebook-activision-blizzard-and-more/,"Lots of Insiders Are Selling Apple, Facebook, Activision Blizzard and More"
ONCE,ONCE:UW,BBG007TJWN87,"ETF’s with exposure to Spark Therapeutics, Inc. : August 15, 2016",2016-08-15 14:41:11 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-spark-therapeutics-inc-august-15-2016/,"ETF’s with exposure to Spark Therapeutics, Inc. : August 15, 2016"
ONCE,ONCE:UW,BBG007TJWN87,"Spark Therapeutics, Inc. :ONCE-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12, 2016",2016-08-12 14:13:01 +0000,http://www.capitalcube.com/blog/index.php/spark-therapeutics-inc-once-us-earnings-analysis-q2-2016-by-the-numbers-august-12-2016/,"Spark Therapeutics, Inc. :ONCE-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12, 2016"
ONCE,ONCE:UW,BBG007TJWN87,"Commit To Purchase Spark Therapeutics At $45, Earn 15.2% Annualized Using Options",2016-08-11 17:49:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/L0IbmeDSYmM/commit-to-purchase-spark-therapeutics-at-45-earn-152-annualized-using-options-cm664217,"Investors eyeing a purchase of Spark Therapeutics Inc (Symbol ONCE) stock, but tentative about paying the going market price of $59.90 share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract"
ONCE,ONCE:UW,BBG007TJWN87,Edited Transcript of ONCE earnings conference call or presentation 10-Aug-16 12:30pm GMT,2016-08-10 20:43:48 +0000,http://finance.yahoo.com/news/edited-transcript-once-earnings-conference-204348453.html,Edited Transcript of ONCE earnings conference call or presentation 10-Aug-16 12:30pm GMT
ONCE,ONCE:UW,BBG007TJWN87,"SPARK THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure,",2016-08-10 12:10:06 +0000,http://biz.yahoo.com/e/160810/once8-k.html,"SPARK THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure,"
ONCE,ONCE:UW,BBG007TJWN87,Spark Therapeutics reports 2Q loss,2016-08-10 11:49:31 +0000,http://sg.finance.yahoo.com/news/spark-therapeutics-reports-2q-loss-114931684.html,Spark Therapeutics reports 2Q loss
ONCE,ONCE:UW,BBG007TJWN87,Spark Therapeutics Announces New Positive Data from Continuation of Phase 3 Trial of Voretigene Neparvovec,2016-08-10 11:40:11 +0000,http://www.publicnow.com/view/7318B977B4EC20CCF3787762C672600F9F426560,"[at noodls] - Of the nine crossover subjects, eight responders demonstrated the maximum improvement measurable on the primary endpoint at one year 27 of 29, or 93%, of Phase 3 subjects that received voretigene neparvovec ..."
ONCE,ONCE:UW,BBG007TJWN87,Spark Therapeutics Reports Second Quarter 2016 Financial Results and Recent Business Highlights,2016-08-10 11:40:03 +0000,http://www.publicnow.com/view/A980F38AED7DA70902FA58865ED439842469F4CA,"[at noodls] - Updated timing of the completed BLA submission for voretigene neparvovec Earlier today, released additional positive data from the pivotal Phase 3 trial of voretigene neparvovec Reported positive preliminary ..."
ONCE,ONCE:UW,BBG007TJWN87,Q2 2016 Spark Therapeutics Inc Earnings Release - Before Market Open,2016-08-10 11:07:02 +0000,http://biz.yahoo.com/research/earncal/20160810.html?t=once,Q2 2016 Spark Therapeutics Inc Earnings Release - Before Market Open
ONCE,ONCE:UW,BBG007TJWN87,"Pre-Market Earnings Report for August 10, 2016 :  JD, PRGO, KORS, ARMK, RL, AVT, OA, ICL, AG, WEN, AGI, ONCE",2016-08-09 20:18:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/iFM9KHrXJrE/pre-market-earnings-report-for-august-10-2016-jd-prgo-kors-armk-rl-avt-oa-icl-ag-wen-agi-once-cm662844,"The following companies are expected to report earnings prior to market open on 08 10 2016. Visit our Earnings Calendar for a full list of expected earnings releases.  JD.com, Inc. ( JD ) is reporting for"
ONCE,ONCE:UW,BBG007TJWN87,"Drug Stock Earnings to Watch on Aug 10: ONCE, COLL & ARGS",2016-08-09 15:38:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/y9sTQ2IwRYY/drug-stock-earnings-to-watch-on-aug-10-once-coll-args-cm662543,"The Q2 earning season is drawing to a close as we now have releases from approximately 433 S&P 500 members, accounting for 87.7% of the index's total market capitalization. Even though earnings put up a 4.1% decline on 0.9%"
ONCE,ONCE:UW,BBG007TJWN87,"Drug Stock Earnings to Watch on Aug 10: ONCE, COLL & ARGS",2016-08-09 13:24:01 +0000,http://finance.yahoo.com/news/drug-stock-earnings-watch-aug-132401834.html,"Drug Stock Earnings to Watch on Aug 10: ONCE, COLL & ARGS"
ONCE,ONCE:UW,BBG007TJWN87,"Spark Therapeutics, Inc. to Host Conference Call on August 10th at 8:30a.m. to Discuss Second Quarter 2016 Results",2016-08-02 11:51:08 +0000,http://www.publicnow.com/view/B9A50ADF639DBF77963BDB3F2A0E721C4123B6C2,"[at noodls] - PHILADELPHIA, Aug. 02, 2016 (GLOBE NEWSWIRE) -- Spark Therapeutics (NASDAQ:ONCE) today announced that it will host a conference call on Wednesday, August 10, 2016 at 8:30 a.m. ET to report corporate and ..."
ONCE,ONCE:UW,BBG007TJWN87,JPMorgan Bullish on Biotech: 3 Top Picks to Buy Now,2016-07-27 12:20:39 +0000,http://247wallst.com/healthcare-business/2016/07/27/jpmorgan-bullish-on-biotech-3-top-picks-to-buy-now/,JPMorgan Bullish on Biotech: 3 Top Picks to Buy Now
ONCE,ONCE:UW,BBG007TJWN87,Health Care Sector Update for 07/25/2016: ONCE,2016-07-25 13:44:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KHpeKNyDJwE/health-care-sector-update-for-07252016-once-cm653993,"Top Health care stocks JNJ 0.1% PFE flat ABT 1.7% MRK +0.1% AMGN +0.5% Health care shares were mixed in pre market trade on Monday. In health care stocks news, Spark Therapeutics ( ONCE ) and Pfizer ( PFE"
ONCE,ONCE:UW,BBG007TJWN87,"Spark Therapeutics and Pfizer Announce Updated Data from First Cohort in Hemophilia B Phase 1/2 Trial Demonstrating Consistent, Sustained Therapeutic Levels of Factor IX Activity",2016-07-25 12:48:02 +0000,http://www.publicnow.com/view/36D6F2B42AC0C4A0DD4086A0427769A28CB890C6,"[at noodls] - PHILADELPHIA and NEW YORK, July 25, 2016 (GLOBE NEWSWIRE) -- Spark Therapeutics (NASDAQ:ONCE) and Pfizer Inc. (NYSE:PFE) announced today updated results of the first cohort from the ongoing Phase 1/2 clinical ..."
ONCE,ONCE:UW,BBG007TJWN87,"Spark Therapeutics, Pfizer Present Updated Data From Ongoing SPK-9001 Trial",2016-07-25 08:48:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VUtXcSpObxU/spark-therapeutics-pfizer-present-updated-data-from-ongoing-spk9001-trial-20160725-00418,"Spark Therapeutics, Pfizer Present Updated Data From Ongoing SPK-9001 Trial"
ONCE,ONCE:UW,BBG007TJWN87,"13 Companies to Watch From MIT's Smart 50 List, Including 4 Buys",2016-07-21 11:48:00 +0000,https://www.thestreet.com/story/13642734/1/13-companies-to-watch-from-mit-s-smart-50-list-including-4-buys.html?puc=yahoo&cm_ven=YAHOO,"13 Companies to Watch From MIT's Smart 50 List, Including 4 Buys"
ONCE,ONCE:UW,BBG007TJWN87,Spark Therapeutics and Pfizer Announce Receipt of FDA Breakthrough Therapy Designation for SPK-9001 for the Treatment of Hemophilia B,2016-07-21 11:30:00 +0000,http://finance.yahoo.com/news/spark-therapeutics-pfizer-announce-receipt-113000146.html,"[GlobeNewswire] - PHILADELPHIA and NEW YORK, July 21, 2016-- Spark Therapeutics and Pfizer Inc. announced today that the U.S. Food and Drug Administration has granted breakthrough therapy designation to SPK-9001, the lead ..."
ONCE,ONCE:UW,BBG007TJWN87,"FDA Grants Breakthrough Therapy Designation For Spark, Pfizer's SPK-9001",2016-07-21 07:56:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jM-ysUUw7hg/fda-grants-breakthrough-therapy-designation-for-spark-pfizers-spk9001-20160721-00398,"FDA Grants Breakthrough Therapy Designation For Spark, Pfizer's SPK-9001"
ONCE,ONCE:UW,BBG007TJWN87,4 Speculative Biotech and Biohealth Analysts Calls for Huge Upside,2016-07-17 14:35:38 +0000,http://247wallst.com/healthcare-business/2016/07/17/4-speculative-biotech-and-biohealth-analysts-calls-for-huge-upside/,4 Speculative Biotech and Biohealth Analysts Calls for Huge Upside
ONCE,ONCE:UW,BBG007TJWN87,Spark Therapeutics Announces Participation in Conferences in July,2016-07-08 11:21:03 +0000,http://www.publicnow.com/view/46E15953D830C73912DE9CDBE5ACF7F22045D3D0,"[at noodls] - PHILADELPHIA, July 08, 2016 (GLOBE NEWSWIRE) -- Spark Therapeutics (NASDAQ:ONCE) announced today that it will participate in the following conferences in July: Cantor Fitzgerald's 2nd Annual Healthcare ..."
ONCE,ONCE:UW,BBG007TJWN87,"ETF’s with exposure to Spark Therapeutics, Inc. : July 5, 2016",2016-07-05 17:09:07 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-spark-therapeutics-inc-july-5-2016/,"ETF’s with exposure to Spark Therapeutics, Inc. : July 5, 2016"
ONCE,ONCE:UW,BBG007TJWN87,Spark Therapeutics Announces Publication of Positive Follow-Up Data from Phase 1 Trial of Voretigene Neparvovec in The Lancet,2016-07-01 11:21:09 +0000,http://www.publicnow.com/view/1F5642E1ABD0B8CE602ABF596AC630D95220EE20,"[at noodls] - PHILADELPHIA, July 01, 2016 (GLOBE NEWSWIRE) -- Spark Therapeutics (NASDAQ:ONCE) announced today the publication in The Lancet of long-term data from a Phase 1 trial of voretigene neparvovec (SPK-RPE65), ..."
ONCE,ONCE:UW,BBG007TJWN87,141 Reasons to Love Biotech Stocks,2016-06-30 23:50:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_XYP8-9lWfU/141-reasons-to-love-biotech-stocks-cm643557,"Image source  Getty Images.  The biotech sector has taken a bit of a beating, down about 24% this year as measured by the iShares NASDAQ Biotechnology Index ETF , and down about 35%"
ONCE,ONCE:UW,BBG007TJWN87,141 Reasons to Love Biotech Stocks,2016-06-30 22:21:00 +0000,http://www.fool.com/investing/2016/06/30/141-reasons-to-love-biotech-stocks.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,141 Reasons to Love Biotech Stocks
ONCE,ONCE:UW,BBG007TJWN87,Cramer: You should be buying this stock hand over fist,2016-06-29 23:36:13 +0000,http://www.cnbc.com/id/103754760?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=103754760,Cramer: You should be buying this stock hand over fist
ONCE,ONCE:UW,BBG007TJWN87,Spark Therapeutics Announces Closing of Public Offering,2016-06-20 20:19:06 +0000,http://www.publicnow.com/view/3506DC6EC75A8735B9EFA6642ABA1A15C9BDAA7D,"[at noodls] - PHILADELPHIA, June 20, 2016 (GLOBE NEWSWIRE) -- Spark Therapeutics, Inc. ('Spark') (NASDAQ:ONCE) announced today the closing of its previously announced underwritten public offering of common stock pursuant ..."
ONCE,ONCE:UW,BBG007TJWN87,"Pre-Market Most Active for Jun 15, 2016 :  TVIX, BP, NOK, XIV, PRGO, FCX, BAC, QQQ, SAN, ONCE, VOD, SIRI",2016-06-15 13:01:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JLPkzriOgzg/pre-market-most-active-for-jun-15-2016-tvix-bp-nok-xiv-prgo-fcx-bac-qqq-san-once-vod-siri-cm635646,"The NASDAQ 100 Pre Market Indicator is up 5.13 to 4,430.04. The total Pre Market volume is currently 5,675,946 shares traded. The following are the most active stocks for the pre market session region ( TVIX ) is 0.09"
ONCE,ONCE:UW,BBG007TJWN87,Spark Therapeutics Announces Pricing of Public Offering,2016-06-15 00:59:01 +0000,http://www.publicnow.com/view/1FEE865163BF2E453C2E35B295794DFF29093E77,"[at noodls] - PHILADELPHIA, June 14, 2016 (GLOBE NEWSWIRE) -- Spark Therapeutics, Inc. ('Spark') (NASDAQ:ONCE) announced today the pricing of an underwritten public offering of 3,500,000 shares of its common stock pursuant ..."
ONCE,ONCE:UW,BBG007TJWN87,ONCE Prices Offering At $45/Share,2016-06-15 00:52:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/R5dMB7VIg2U/once-prices-offering-at-45share-20160615-00010,ONCE Prices Offering At $45/Share
ONCE,ONCE:UW,BBG007TJWN87,Spark Therapeutics Announces Launch of Public Offering,2016-06-13 21:09:07 +0000,http://www.publicnow.com/view/B0E7DCE8866527C8B76060927CE9553B430C205C,"[at noodls] - PHILADELPHIA, June 13, 2016 (GLOBE NEWSWIRE) -- Spark Therapeutics, Inc. ('Spark') (NASDAQ:ONCE) announced today that it has commenced an underwritten public offering of 3,500,000 shares of its common ..."
ONCE,ONCE:UW,BBG007TJWN87,"Spark Therapeutics Announces Updated Data from First Cohort in Hemophilia B Phase 1/2 Trial Demonstrating Consistent, Sustained Therapeutic Levels of Factor IX Activity",2016-06-13 11:39:03 +0000,http://www.publicnow.com/view/3ED3015228E8E7BDAD03595A7E2614B25D90CD3D,"[at noodls] - All four subjects received one-time administration of SPK-9001 at initial low dose for a cumulative 58-weeks of follow-up without the need for immunosuppression Lead investigational candidate, SPK-8011, ..."
ONCE,ONCE:UW,BBG007TJWN87,"Spark Therapeutics, Inc. to Host Conference Call on Monday June 13th at 8:30 a.m. to Discuss SPK-9001 Phase 1/2 Data for the Treatment of Hemophilia B Presented at EHA",2016-06-09 11:39:07 +0000,http://www.publicnow.com/view/6FF9246B8D90938114DEA46227379B9B64A3AFD0,"[at noodls] - PHILADELPHIA, June 09, 2016 (GLOBE NEWSWIRE) -- Spark Therapeutics (NASDAQ:ONCE) announced today that it will host a conference call on Monday, June 13, 2016 at 8:30 a.m. ET to discuss updated results ..."
ONCE,ONCE:UW,BBG007TJWN87,Spark Therapeutics Announces Participation and Attendance for Conferences in June,2016-06-06 11:48:10 +0000,http://www.publicnow.com/view/B540C54BD2B7AEF070BEC1BB66313254250806B3,"[at noodls] - PHILADELPHIA, June 06, 2016 (GLOBE NEWSWIRE) -- Spark Therapeutics (NASDAQ:ONCE) announced today that members of its management team will participate in and attend the following conferences in June: Presenting ..."
ONCE,ONCE:UW,BBG007TJWN87,Pfizer's (PFE) Trumenba Accepted for Review in the EU,2016-05-23 16:49:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bD-U_Fa_BZg/pfizers-pfe-trumenba-accepted-for-review-in-the-eu-cm624955,Pfizer Inc.PFE announced that the European Medicines Agency has accepted for review the marketing authorization application for Trumenba (meningococcal group B vaccine). The acceptance marks the initiation of the EMA's review process for the vaccine. Pfizer is looking to
ONCE,ONCE:UW,BBG007TJWN87,Why Spark Therapeutics Caught Fire and Rallied Higher Today,2016-05-19 21:48:19 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TFT9SjfB14U/why-spark-therapeutics-caught-fire-and-rallied-higher-today-cm623803,"Image source  Flickr user Steve Jurvetson.  What   After Spark Therapeutics (NASDAQ  ONCE)  reported promising results from a small early stage drug trial, its shares skyrocketed by 12.4% today.  So what"
ONCE,ONCE:UW,BBG007TJWN87,"Notable Thursday Option Activity: SMRT, RMTI, ONCE",2016-05-19 20:45:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jqlSBnS2jZM/notable-thursday-option-activity-smrt-rmti-once-cm623750,"Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Stein Mart, Inc. (Symbol SMRT), where a total volume of 2,060 contracts has been traded thus far today, a contract volume"
ONCE,ONCE:UW,BBG007TJWN87,"Health Care Sector Update for 05/19/2016: ONCE,PFE,KOOL,RGEN",2016-05-19 20:19:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lVzwqWVKvN4/health-care-sector-update-for-05192016-oncepfekoolrgen-cm623772,"Top Health Care Stocks JNJ 0.75% PFE +0.72% MRK 1.53% ABT 0.31% AMGN 1.45% Health care stocks were finishing above their worst levels of Thursday trading, with the NYSE Health Care Index posting a 0.9% slump while shares of"
ONCE,ONCE:UW,BBG007TJWN87,Spark Therapeutics and Pfizer Announce Data from Initial Subjects in Hemophilia B Trial Demonstrating Consistent Therapeutic Levels of Factor IX Expression,2016-05-19 10:52:05 +0000,http://www.publicnow.com/view/DE63BC3D5AD62445076155646927E7CA0DEDCC8A,[at noodls] - Subjects received one-time administration of a highly optimized gene therapy at initial low dose without the need for immunosuppression Therapeutic Factor IX activity sustained at levels exceeding those ...
ONCE,ONCE:UW,BBG007TJWN87,Spark Therapeutics Inc. (ONCE) Is Up Sharply On Study Data,2016-05-19 10:00:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/WeduGgFIfuw/spark-therapeutics-inc-once-is-up-sharply-on-study-data-20160519-00699,Spark Therapeutics Inc. (ONCE) Is Up Sharply On Study Data
ONCE,ONCE:UW,BBG007TJWN87,"Spark, Pfizer Announce Data From Initial Subjects In Hemophilia B Trial",2016-05-19 06:40:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3EXwUbgybR4/spark-pfizer-announce-data-from-initial-subjects-in-hemophilia-b-trial-20160519-00182,"Spark, Pfizer Announce Data From Initial Subjects In Hemophilia B Trial"
ONCE,ONCE:UW,BBG007TJWN87,"Health Care Sector Update for 05/04/2016: ONCE, JNP",2016-05-04 13:46:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OD97RL7-VqA/health-care-sector-update-for-05042016-once-jnp-cm616003,"Top Health care stocks JNJ 0.1% PFE +2.7% ABT 0.8% MRK 0.4% AMGN flat Health care shares were lower in pre market trade on Wednesday. In health care stocks news, Gene therapy company Spark Therapeutics ( ONCE ) reported"
ONCE,ONCE:UW,BBG007TJWN87,Spark Therapeutics reports 1Q loss,2016-05-04 12:42:40 +0000,http://sg.finance.yahoo.com/news/spark-therapeutics-reports-1q-loss-124240403.html,Spark Therapeutics reports 1Q loss
ONCE,ONCE:UW,BBG007TJWN87,Spark Therapeutics Reports First Quarter 2016 Financial Results and Recent Business Highlights,2016-05-04 11:50:01 +0000,http://www.publicnow.com/view/B6826F8A6DE63818C694E7C3604C2F65D5311072,"[at noodls] - Company makes progress across multiple programs Appoints Daniel R. Faga as Chief Business Officer PHILADELPHIA, May 04, 2016 (GLOBE NEWSWIRE) -- Spark Therapeutics (NASDAQ:ONCE) today announced financial ..."
ONCE,ONCE:UW,BBG007TJWN87,Spark Therapeutics Announces Multiple Presentations at Upcoming Investor Meetings,2016-05-03 21:30:08 +0000,http://www.publicnow.com/view/CC2D03CF36F6986C1DF3B0909F26912364C3CAFC,"[at noodls] - PHILADELPHIA, May 03, 2016 (GLOBE NEWSWIRE) -- Spark Therapeutics (NASDAQ:ONCE) today announced that members of its management team will participate in three upcoming conferences in May: Deutsche Bank ..."
ONCE,ONCE:UW,BBG007TJWN87,Spark Therapeutics Announces Multiple Presentations at Upcoming Scientific Meetings,2016-04-28 21:31:05 +0000,http://www.publicnow.com/view/D9A390983128A4AFDB188D9077C357A1CD9F9073,"[at noodls] - PHILADELPHIA, April 28, 2016 (GLOBE NEWSWIRE) -- Spark Therapeutics (NASDAQ:ONCE) today announced that researchers will make multiple presentations related to the company's broad gene therapy development ..."
ONCE,ONCE:UW,BBG007TJWN87,"Spark Therapeutics, Inc. to Host Conference Call on May 4th at 8:30a.m. to Discuss First Quarter 2016 Results",2016-04-27 11:11:31 +0000,http://www.publicnow.com/view/BEBE8B714AA8704707DA3B6F3F054F601E43935F,"[at noodls] - PHILADELPHIA, April 27, 2016 (GLOBE NEWSWIRE) -- Spark Therapeutics (NASDAQ:ONCE) today announced that it will host a conference call on Wednesday, May 4, 2016 at 8:30 a.m. ET to report corporate and financial ..."
ONCE,ONCE:UW,BBG007TJWN87,"The Zacks Analyst Blog Highlights: Interactive Brokers Group, Yirendai, Spark Therapeutics, Versartis and Accelerate Diagnostics",2016-04-22 15:26:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ODoJO5LjJIY/the-zacks-analyst-blog-highlights-interactive-brokers-group-yirendai-spark-therapeutics-versartis-and-accelerate-diagnostics-cm610103,"For Immediate Release Chicago, IL April 22, 2016 Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks"
ONCE,ONCE:UW,BBG007TJWN87,5 Stocks with Rising Analyst Coverage,2016-04-21 23:23:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TLavZ79hhBs/5-stocks-with-rising-analyst-coverage-cm609862,"Why do analysts initiate coverage on a particular stock? Of course, stocks are not randomly covered by analysts. New or increased coverage on a stock is usually the result of huge investor focus on it or its promising future"
ONCE,ONCE:UW,BBG007TJWN87,No IPO in sight: GenSight Biologics withdraws $65 million IPO,2016-04-14 21:22:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1P4UQVn1EOo/no-ipo-in-sight-gensight-biologics-withdraws-65-million-ipo-cm606586,"GenSight Biologics, which is developing gene therapies for rare retinal diseases, withdrew its plans for an initial public offering on Thursday. It had filed to raise $65 million by offering 4.7 million shares at a price range of $13"
ONCE,ONCE:UW,BBG007TJWN87,Implied XBI Analyst Target Price: $90,2016-03-24 13:09:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dGZ4u5QgyKM/implied-xbi-analyst-target-price-90-cm597248,"Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel , we have compared the trading price of each holding against the average analyst 12 month forward target price, and computed the weighted average"
ONCE,ONCE:UW,BBG007TJWN87,Spark Therapeutics Announces Addition of Lota Zoth to Its Board of Directors,2016-01-06 21:25:09 +0000,http://www.noodls.com/view/B5DB992DEE08217E8B4E43298F5985F3C879FE66,[at noodls] - Spark Therapeutics Announces Addition of Lota Zoth to Its Board of Directors
ONCE,ONCE:UW,BBG007TJWN87,Spark Therapeutics reports 3Q loss,2015-11-04 13:15:37 +0000,http://sg.finance.yahoo.com/news/spark-therapeutics-reports-3q-loss-131537413.html,Spark Therapeutics reports 3Q loss
